DANA-FARBER CANCER INSTITUTE: Form 990, tax year 2021
View the entire original 990 at ProPublica ↗
- Organization
- DANA-FARBER CANCER INSTITUTE (EIN 04-2263040)
- Tax period
- 2021-10-01 to 2022-09-30
- Filed
- 2023-08-04
- IRS object ID
- 202322169349300907
- Schema version
- 2021v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule H
- Schedule I
- Schedule J
- Schedule K
- Schedule K
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-08-04T14:00:16+00:00 | ReturnTs |
| Tax Period End | 2022-09-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 346565596 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ERNST YOUNG US LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | ONE MANHATTAN WEST | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100018604 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2021-10-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 042263040 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Dana-Farber Cancer Institute Inc | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | DANA | BusinessNameControlTxt |
| Phone | 6176323000 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 450 BROOKLINE AVENUE BP418 | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02215 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MICHAEL L RENEY | PersonNm |
| Person Title | CFO ASSISTANT TREASURER | PersonTitleTxt |
| Phone | 6176323000 | PhoneNum |
| Signature | 2023-08-04 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | MICHAEL | PersonFirstNm |
| Person Last | RENEY | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Nicole Sokolowski | PreparerPersonNm |
| PTIN | P01683199 | PTIN |
| Phone | 2127733000 | PhoneNum |
| Preparation | 2023-07-31 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2021 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
Principal Ofcr Business Name PrincipalOfcrBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | LAURIE H GLIMCHER MD | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 450 BROOKLINE AVENUE BP418 | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02215 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $2,672,062,824 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.DANA-FARBER.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1951 | FormationYr |
| Legal Domicile State | MA | LegalDomicileStateCd |
| Activity Or Mission | SEE SCHEDULE O | ActivityOrMissionDesc |
| Voting Members Governing Body | 67 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 66 | VotingMembersIndependentCnt |
| Total Employee | 7998 | TotalEmployeeCnt |
| Total Volunteers | 500 | TotalVolunteersCnt |
| Total Gross UBI | $65,661 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $48,113 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $726,297,460 | PYContributionsGrantsAmt |
| CY Contributions Grants | $702,430,542 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $1,571,455,891 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $1,911,183,785 | CYProgramServiceRevenueAmt |
| PY Investment Income | $260,510 | PYInvestmentIncomeAmt |
| CY Investment Income | $928,841 | CYInvestmentIncomeAmt |
| PY Other Revenue | $119,781,469 | PYOtherRevenueAmt |
| CY Other Revenue | $54,541,425 | CYOtherRevenueAmt |
| PY Total Revenue | $2,417,795,330 | PYTotalRevenueAmt |
| CY Total Revenue | $2,669,084,593 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $5,380,564 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $6,990,590 | CYGrantsAndSimilarPaidAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $714,320,194 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $807,894,359 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $3,975,124 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $3,929,270 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $44,756,956 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $1,502,166,122 | PYOtherExpensesAmt |
| CY Other Expenses | $1,739,890,313 | CYOtherExpensesAmt |
| PY Total Expenses | $2,225,842,004 | PYTotalExpensesAmt |
| CY Total Expenses | $2,558,704,532 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $191,953,326 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $110,380,061 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $4,549,977,055 | TotalAssetsBOYAmt |
| Total Assets EOY | $4,291,020,227 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $1,605,907,385 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $1,487,687,279 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $2,944,069,670 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $2,803,332,948 | NetAssetsOrFundBalancesEOYAmt |
| Mission | SEE SCHEDULE O | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $1,612,588,676 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $1,911,183,785 | RevenueAmt |
| Desc | CLINICAL CARE - SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $671,083,292 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | RESEARCH - SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $38,076,070 | ExpenseAmt |
| Grant | $6,990,590 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | COMMUNITY BENEFITS - SEE SCHEDULE O | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $2,321,748,038 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (true) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (true) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | false | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | Yes (true) | OperateHospitalInd |
| Audited Financial Stmt Att | Yes (true) | AuditedFinancialStmtAttInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (true) | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | Yes (true) | TaxExemptBondsInd |
| Invest Tax Exempt Bonds | false | InvestTaxExemptBondsInd |
| Escrow Account | false | EscrowAccountInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (true) | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | Yes (true) | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (true) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| Info In Schedule O Part V | Yes (X) | InfoInScheduleOPartVInd |
| IRP Document | 677 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 7998 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | CJ | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (true) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 67 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 66 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (true) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MELISSA CHAMMAS | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 6176323000 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 450 BROOKLINE AVE BP418 | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02115 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (94 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|---|
| JOHN J O'CONNOR | ||||||||||
| Trustee Treasurer | 2.0 | 4.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| JOSHUA BEKENSTEIN | ||||||||||
| Trustee Chairman | 2.0 | 4.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| Laurie H Glimcher MD | ||||||||||
| TRUSTEE, PRESIDENT, AND CEO | 44.0 | 6.0 | Yes (X) | Yes (X) | $3,672,655 | $0 | $321,403 | |||
| Monica Chandra | ||||||||||
| Trustee Secretary | 1.0 | 2.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| Richard Lubin | ||||||||||
| Trustee Vice-Chairman | 2.0 | 0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| Afsaneh Beschloss | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Alison Jaffe | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Amy Berylson | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Amy Kyle ESQ | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Andrew Janower | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Andrew Kaplan | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Beth Terrana | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Betty Ann Blum | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Bradley Lucas | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Brian Knez | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Christopher Hadley | ||||||||||
| Trustee | 1.0 | 1.0 | Yes (X) | $0 | $0 | $0 | ||||
| Demond Martin | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Doug Grip | ||||||||||
| Trustee (as of 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Eric Miller | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Eric Schlager | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Esta Stecher | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Fatima Penrose | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Frederica Williams | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Harvey Berger MD | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Hise Gibson | ||||||||||
| Trustee (as of 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| James McCann | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Jane Brock-Wilson | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Jane Jamieson | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Jennifer Perini | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Jessica Knez | ||||||||||
| Trustee (as of 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Jill Greenthal | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Jodi Walker | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Jose Aguerrevere | ||||||||||
| Trustee (as of 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Joseph Norberg | ||||||||||
| Trustee (END 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Karen Daley PHD MPH RN FANN | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Karen Linde Packman | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Kate Gulliver | ||||||||||
| Trustee (as of 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Kevin DaSilva | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Kimberly Sherman Stamler | ||||||||||
| Trustee (as of 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Laura Sen | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Lisa Ferraro | ||||||||||
| Trustee (as of 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Lori Whelan | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Louise Svanberg | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Mary Ann Tocio | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Meg Reynolds | ||||||||||
| Trustee (as of 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Michael Eisenson | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Michael Trotsky | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Moria Forbes | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Nancy Gibson | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Nancy Lotane | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Paul Marcus | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Peter Palandjian | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Phillip Gross | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Robert Reynolds | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Robert Sachs | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Robert Stansky | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Roger Berkowitz | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Roger Medel | ||||||||||
| Trustee (END 1/31/22) | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Ronald Sullivan | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Sandra Stratford MD | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Stephen Fine | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Stephen Koster ESQ | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Steven Koppel | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Susan Alexander ESQ | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Susan Poduska | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Sushil Tuli | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Theodore Pasquarello | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Timothy Cohen | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Tracey McCain ESQ | ||||||||||
| Trustee | 1.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| Jennifer Willcox ESQ | ||||||||||
| Asst. Sec. GC (Begin 6/1/22) | 50.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| John O Chesley ESQ | ||||||||||
| Asst. Sec. GC (Begin 1/14/22) | 50.0 | 0 | Yes (X) | $0 | $0 | $0 | ||||
| John Ryan ESQ | ||||||||||
| Asst. Sec. Gen. Cnsl. (End 1/14/22) | 46.0 | 4.0 | Yes (X) | $617,744 | $0 | $31,945 | ||||
| Michael L Reney | ||||||||||
| CFO Assistant Treasurer | 44.0 | 6.0 | Yes (X) | $835,469 | $0 | $37,481 | ||||
| William Hahn MD PHD | ||||||||||
| COO EVP | 48.0 | 2.0 | Yes (X) | $855,136 | $0 | $37,402 | ||||
| Barrett J Rollins MD PHD | ||||||||||
| Sr. Advisor President CEO | 50.0 | 0 | $513,026 | $0 | $51,441 | Yes (X) | ||||
| Benjamin Ebert MD PhD | ||||||||||
| Chair of Medical Oncology | 50.0 | 0 | $199,529 | $0 | $8,869 | Yes (X) | ||||
| Craig A Bunnell MD | ||||||||||
| Chief Medical Officer | 50.0 | 0 | $762,033 | $0 | $40,568 | Yes (X) | ||||
| Jeffrey Meyerhardt MD PhD | ||||||||||
| Chief Clinical Research Officer | 49.0 | 1.0 | $488,567 | $0 | $70,862 | Yes (X) | ||||
| Kevin Haigis | ||||||||||
| Chief Scientific Officer | 50.0 | 0 | $524,839 | $0 | $58,480 | Yes (X) | ||||
| Maria Megdal | ||||||||||
| SVP of Institue Operations | 50.0 | 0 | $518,918 | $0 | $52,529 | Yes (X) | ||||
| Melany Duval | ||||||||||
| SVP of Development | 50.0 | 0 | $725,483 | $0 | $51,770 | Yes (X) | ||||
| Sylvia A Bartel RPh MHP | ||||||||||
| VP of Pharmacy Services | 50.0 | 0 | $321,990 | $0 | $65,749 | Yes (X) | ||||
| Wendy Gettleman | ||||||||||
| VP of Facilities Management Real Estate | 50.0 | 0 | $347,799 | $0 | $69,288 | Yes (X) | ||||
| Edward J Benz JR MD | ||||||||||
| President CEO Emeritus | 50.0 | 0.0 | $2,163,654 | $0 | $51,485 | Yes (X) | ||||
| Eric Winer MD | ||||||||||
| Chief of Div. of Women's Cancers | 50.0 | 0 | $797,539 | $0 | $47,595 | Yes (X) | ||||
| Matthew Meyerson MD | ||||||||||
| Professor | 50.0 | 0 | $903,547 | $0 | $69,876 | Yes (X) | ||||
| Michael Constantine MD | ||||||||||
| Milford Medical Dir. - Hematol Onc. | 50.0 | 0 | $758,741 | $0 | $58,121 | Yes (X) | ||||
| Robert Soiffer MD | ||||||||||
| Chief of Hemotologic Malignancies | 50.0 | 0 | $712,796 | $0 | $54,177 | Yes (X) | ||||
| Bruce Johnson MD | ||||||||||
| Senior Advisor to President CEO | 49.0 | 1.0 | $671,141 | $0 | $56,584 | Yes (X) | ||||
| Drew Memmott | ||||||||||
| Former Key Employee | 50.0 | 0 | $301,819 | $0 | $39,066 | Yes (X) | ||||
| Elizabeth Liebow | ||||||||||
| Chief Integration Officer | 50.0 | 0 | $458,662 | $0 | $54,674 | Yes (X) | ||||
| James D Griffin MD | ||||||||||
| Professor of Medicine | 50.0 | 0 | $681,419 | $0 | $59,640 | Yes (X) | ||||
| James Terwilliger | ||||||||||
| Former Officer | 0.0 | 0 | $360,500 | $0 | $0 | Yes (X) | ||||
| Richard S Boskey ESQ | ||||||||||
| Former Officer | 50.0 | 0 | $799,400 | $0 | $51,348 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $18,992,406 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $1,440,353 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 1826 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (true) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| BRIGHAM AND WOMEN'S HOSPITAL | |||||
| 399 Revolution Drive Ste 645 | SOMERVILLE | MA | 02145 | MEDICAL SERVICES | $121,637,106 |
| MASS GENERAL BRIGHAM INC | |||||
| 399 Revolution Drive Ste 645 | SOMERVILLE | MA | 01245 | INFORMATION SYS | $71,888,137 |
| CARDINAL HEALTH | |||||
| 736 Cambridge St | BRIGHTON | MA | 02135 | MEDICAL SERVICES | $34,256,935 |
| SOUTH SHORE HOSPITAL | |||||
| 55 Fogg Rd | South Weymouth | MA | 02190 | MEDICAL SERVICES | $23,198,171 |
| BRIGHAM AND WOMEN'S PHYSICIANS ORG | |||||
| 75 Francis Street | BOSTON | MA | 02115 | MEDICAL SERVICES | $18,088,258 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 591 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $158,395 | FederatedCampaignsAmt |
| Fundraising | $21,847,790 | FundraisingAmt |
| Related Organizations | $637,712 | RelatedOrganizationsAmt |
| Government Grants | $199,360,295 | GovernmentGrantsAmt |
| All Other Contributions | $480,426,350 | AllOtherContributionsAmt |
| Noncash Contributions | $23,318,827 | NoncashContributionsAmt |
| Total Contributions | $702,430,542 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| NET PATIENT SERVICE REVENUE | 621110 | $1,896,457,895 | $1,896,457,895 |
| NETWORK COLLABORATION | 900099 | $12,022,552 | $12,022,552 |
| LINAC | 621500 | $2,703,338 | $2,703,338 |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $1,911,183,785 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $928,841 | TotalRevenueColumnAmt |
| Exclusion | $928,841 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $42,392,706 | TotalRevenueColumnAmt |
| Exclusion | $42,392,706 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $1,529,977 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $1,529,977 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,529,977 | TotalRevenueColumnAmt |
| Exclusion | $1,529,977 | ExclusionAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $0 | SecuritiesAmt |
| Other | $0 | OtherAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $605,256 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $21,847,790 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $2,978,231 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$2,372,975 | TotalRevenueColumnAmt |
| Exclusion | -$2,372,975 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| PARKING LOT REVENUE | 812930 | $4,721,708 | $4,721,708 |
| FOOD SERVICE REVENUE | 722210 | $3,633,966 | $3,633,966 |
| SURPLUS CAPITAL DISTRIBUTION | 524298 | $1,820,768 | $1,820,768 |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,815,275 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $65,661 | UnrelatedBusinessRevenueAmt |
| Exclusion | $2,749,614 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $12,991,717 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,669,084,593 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,911,183,785 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $65,661 | UnrelatedBusinessRevenueAmt |
| Exclusion | $55,404,605 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,443,246 | TotalAmt |
| Program Services | $4,443,246 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,547,344 | TotalAmt |
| Program Services | $2,547,344 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,054,329 | TotalAmt |
| Program Services | $3,481,125 | ProgramServicesAmt |
| Management And General | $6,847,721 | ManagementAndGeneralAmt |
| Fundraising | $725,483 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,765,454 | TotalAmt |
| Program Services | $1,140,081 | ProgramServicesAmt |
| Management And General | $3,625,373 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $636,395,164 | TotalAmt |
| Program Services | $545,848,481 | ProgramServicesAmt |
| Management And General | $63,456,950 | ManagementAndGeneralAmt |
| Fundraising | $27,089,733 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $39,145,764 | TotalAmt |
| Program Services | $29,777,298 | ProgramServicesAmt |
| Management And General | $7,664,120 | ManagementAndGeneralAmt |
| Fundraising | $1,704,346 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $71,561,012 | TotalAmt |
| Program Services | $54,434,845 | ProgramServicesAmt |
| Management And General | $14,010,511 | ManagementAndGeneralAmt |
| Fundraising | $3,115,656 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $44,972,636 | TotalAmt |
| Program Services | $34,209,668 | ProgramServicesAmt |
| Management And General | $8,804,929 | ManagementAndGeneralAmt |
| Fundraising | $1,958,039 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,741,130 | TotalAmt |
| Program Services | $4,247,889 | ProgramServicesAmt |
| Management And General | $487,827 | ManagementAndGeneralAmt |
| Fundraising | $5,414 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $26,180,303 | TotalAmt |
| Program Services | $14,465,034 | ProgramServicesAmt |
| Management And General | $11,589,640 | ManagementAndGeneralAmt |
| Fundraising | $125,629 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $542,794 | TotalAmt |
| Management And General | $542,794 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $644,136 | TotalAmt |
| Program Services | $644,136 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,929,270 | TotalAmt |
| Fundraising | $3,929,270 | FundraisingAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $215,561,760 | TotalAmt |
| Program Services | $196,501,409 | ProgramServicesAmt |
| Management And General | $18,061,561 | ManagementAndGeneralAmt |
| Fundraising | $998,790 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,264,415 | TotalAmt |
| Program Services | $12,693,091 | ProgramServicesAmt |
| Management And General | $1,213,145 | ManagementAndGeneralAmt |
| Fundraising | $2,358,179 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $32,299,521 | TotalAmt |
| Program Services | $27,228,536 | ProgramServicesAmt |
| Management And General | $3,951,806 | ManagementAndGeneralAmt |
| Fundraising | $1,119,179 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $87,398,652 | TotalAmt |
| Program Services | $84,421,215 | ProgramServicesAmt |
| Management And General | $2,907,287 | ManagementAndGeneralAmt |
| Fundraising | $70,150 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $139,852,649 | TotalAmt |
| Program Services | $113,725,536 | ProgramServicesAmt |
| Management And General | $26,126,016 | ManagementAndGeneralAmt |
| Fundraising | $1,097 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,510,455 | TotalAmt |
| Program Services | $7,099,534 | ProgramServicesAmt |
| Management And General | $354,864 | ManagementAndGeneralAmt |
| Fundraising | $56,057 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,034,054 | TotalAmt |
| Program Services | $1,260,219 | ProgramServicesAmt |
| Management And General | $736,941 | ManagementAndGeneralAmt |
| Fundraising | $1,036,894 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $22,743,748 | TotalAmt |
| Program Services | $22,508,042 | ProgramServicesAmt |
| Management And General | $235,706 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $99,285,716 | TotalAmt |
| Program Services | $90,017,712 | ProgramServicesAmt |
| Management And General | $9,268,004 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,811,062 | TotalAmt |
| Program Services | $112,235 | ProgramServicesAmt |
| Management And General | $6,698,827 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| PHARMACEUTICALS | $892,448,551 | $892,448,551 | |
| MEDICAL SUPPLIES | $125,368,108 | $125,209,989 | $158,119 |
| OTHER PATIENT CARE EXPENSE | $36,904,529 | $36,904,529 | |
| BAD DEBT EXPENSE | $12,841,731 | $12,841,731 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,456,999 | TotalAmt |
| Program Services | $3,536,562 | ProgramServicesAmt |
| Management And General | $5,457,397 | ManagementAndGeneralAmt |
| Fundraising | $463,040 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,558,704,532 | TotalAmt |
| Program Services | $2,321,748,038 | ProgramServicesAmt |
| Management And General | $192,199,538 | ManagementAndGeneralAmt |
| Fundraising | $44,756,956 | FundraisingAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $152,104,020 | BOYAmt |
| EOY | $65,115,214 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $76,057,876 | BOYAmt |
| EOY | $62,120,796 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $213,493,799 | BOYAmt |
| EOY | $260,144,499 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $860,126 | BOYAmt |
| EOY | $682,778 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $66,954,755 | BOYAmt |
| EOY | $75,159,880 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $64,357,187 | BOYAmt |
| EOY | $84,658,692 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $2,156,070,835 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $1,199,462,066 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,003,675,664 | BOYAmt |
| EOY | $956,608,769 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,894,580 | BOYAmt |
| EOY | $7,894,580 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,964,579,048 | BOYAmt |
| EOY | $2,778,635,019 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,549,977,055 | BOYAmt |
| EOY | $4,291,020,227 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $305,173,992 | BOYAmt |
| EOY | $234,183,543 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $501,804,498 | BOYAmt |
| EOY | $494,845,000 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $72,978,317 | BOYAmt |
| EOY | $71,236,000 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $725,950,578 | BOYAmt |
| EOY | $687,422,736 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,605,907,385 | BOYAmt |
| EOY | $1,487,687,279 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,354,436,047 | BOYAmt |
| EOY | $1,364,120,082 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,589,633,623 | BOYAmt |
| EOY | $1,439,212,866 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,944,069,670 | BOYAmt |
| EOY | $2,803,332,948 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,549,977,055 | BOYAmt |
| EOY | $4,291,020,227 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $110,380,061 | ReconcilationRevenueExpnssAmt |
| Other Changes In Net Assets | -$251,116,783 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $561,378,936 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $604,363,420 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $629,412,126 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $726,297,460 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $702,430,542 | CurrentTaxYearAmt |
| Total | $3,223,882,484 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $561,378,936 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $604,363,420 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $629,412,126 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $726,297,460 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $702,430,542 | CurrentTaxYearAmt |
| Total | $3,223,882,484 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $0 | SubstantialContributorsTotAmt |
| Public Support Total170 | $3,223,882,484 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $9,629,978 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $101,304,972 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $52,614,894 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $113,415,703 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $44,851,524 | CurrentTaxYearAmt |
| Total | $321,817,071 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus3 Years | $88,157 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $126,581 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $93,395 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $65,661 | CurrentTaxYearAmt |
| Total | $373,794 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $23,432,437 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $14,052,058 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $14,915,439 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $7,706,225 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $13,596,972 | CurrentTaxYearAmt |
| Total | $73,703,131 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $3,619,776,480 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $7,286,184,749 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.8906 | PublicSupportCY170Pct |
| Public Support PY170 | 0.9105 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule A, Part II, Line 10 Other Income | FormAndLineReferenceDesc |
| Explanation | DESCRIPTION - PARKING LOT REVENUE, COLUMN A - 5813650.0, COLUMN B - 6073362.0, COLUMN C - 3877282.0, COLUMN D - 3167144.0, COLUMN E - 4721708.0, COLUMN F - 23653146.0; DESCRIPTION - FOOD SERVICE REVENUE, COLUMN A - 4038106.0, COLUMN B - 4291088.0, COLUMN C - 2743883.0, COLUMN D - 2516332.0, COLUMN E - 3633966.0, COLUMN F - 17223375.0; DESCRIPTION - SURPLUS CAPITAL DISTRIBUTION, COLUMN A - 1073088.0, COLUMN B - 1113069.0, COLUMN C - 647635.0, COLUMN D - 698598.0, COLUMN E - 1820768.0, COLUMN F - 5353158.0; DESCRIPTION - MISCELLANOUS REVENUE, COLUMN A - 11584400.0, COLUMN B - 1661376.0, COLUMN C - 7376177.0, COLUMN D - 1067783.0, COLUMN E - 2815275.0, COLUMN F - 24505011.0; DESCRIPTION - FUNDRAISING EVENTS, COLUMN A - 923193.0, COLUMN B - 913163.0, COLUMN C - 270462.0, COLUMN D - 256368.0, COLUMN E - 605255.0, COLUMN F - 2968441.0; | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | Yes (true) | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | Yes (true) | GrantsOtherOrganizationsInd |
| Grants Other Organizations | $376,725 | GrantsOtherOrganizationsAmt |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $267,411 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | false | OtherActivitiesInd |
| Total Lobbying Expenditures | $644,136 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule C, Part II-B | FormAndLineReferenceDesc |
| Explanation | VAN SCOYOC ASSOCIATES PROVIDED FEDERAL LEGISLATIVE CONSULTING FOR DANA-FARBER CANCER INSTITUTE, INC. (DFCI). MCDERMOTT, QUILTY MILLER, LLP PROVIDED STATE LEGISLATIVE AND GOVERNMENT RELATIONS CONSULTING FOR DFCI. CONFERENCE OF BOSTON TEACHING HOSPITALS PROVIDED STATE AND FEDERAL LOBBYING SUPPORT TO DFCI. ALLIANCE OF DEDICATED CANCER CENTERS REPRESENTS THE NATION'S TEN FREESTANDING CANCER CENTERS. WE WORK TOGETHER ON FEDERAL REGULATORY, LEGISLATIVE, AND REIMBURSEMENT ISSUES UNIQUE TO DEDICATED CANCER CENTERS. CQ ROLL CALL PROVIDES GRASSROOTS ADVOCACY SOFTWARE USED FOR EMAILS AND ACTION ALERTS ON ADVOCACY ISSUES WHICH ARE SENT TO MEMBERS OF DANA-FARBER'S LEGISLATIVE ACTION NETWORK (LAN). DFCI'S LAN ADVOCATES FOR LEGISLATION AND POLICIES THAT IMPROVE THE LIVES OF CANCER PATIENTS. DFCI IS A MEMBER OF THE AMERICAN HOSPITAL ASSOCIATION AND THE MASSACHUSETTS HOSPITAL ASSOCIATION, NOT-FOR-PROFIT ORGANIZATIONS THAT REPRESENT AND ADVOCATE FOR THE COLLECTIVE INTERESTS OF THEIR MEMBER HOSPITALS AND HEALTH SYSTEMS THROUGH LEADERSHIP IN PUBLIC ADVOCACY, EDUCATION, AND INFORMATION. A PORTION OF THE MEMBERSHIP DUES TO THESE ORGANIZATIONS ARE USED FOR LOBBYING ACTIVITIES. ON OCCASION, DFCI EXECUTIVE LEADERSHIP MEET WITH STATE AND FEDERAL ELECTED OFFICIALS TO ADVOCATE FOR THE PASSAGE OF LEGISLATION AND FUNDING TO ADVANCE CANCER RESEARCH AND TREATMENT, AND LEGISLATION TO SUPPORT SERVICES FOR CANCER PATIENTS AND CANCER SURVIVORS. IN ADDITION, DFCI SUBMITS LETTERS AND/OR TESTIMONY TO ELECTED OFFICIALS AND POLICY MAKERS ON THESE ISSUES. | ExplanationTxt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $479,196,000 | BeginningYearBalanceAmt |
| Contributions | $29,347,000 | ContributionsAmt |
| Investment Earnings Or Losses | -$55,371,000 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $22,902,000 | OtherExpendituresAmt |
| End Year Balance | $430,270,000 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $357,421,000 | BeginningYearBalanceAmt |
| Contributions | $14,528,000 | ContributionsAmt |
| Investment Earnings Or Losses | $122,237,000 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $14,990,000 | OtherExpendituresAmt |
| End Year Balance | $479,196,000 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $313,020,000 | BeginningYearBalanceAmt |
| Contributions | $21,879,000 | ContributionsAmt |
| Investment Earnings Or Losses | $41,043,000 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $18,521,000 | OtherExpendituresAmt |
| End Year Balance | $357,421,000 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $301,578,000 | BeginningYearBalanceAmt |
| Contributions | $11,140,000 | ContributionsAmt |
| Investment Earnings Or Losses | $18,454,000 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $18,152,000 | OtherExpendituresAmt |
| End Year Balance | $313,020,000 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $276,248,000 | BeginningYearBalanceAmt |
| Contributions | $12,288,000 | ContributionsAmt |
| Investment Earnings Or Losses | $30,131,000 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $17,089,000 | OtherExpendituresAmt |
| End Year Balance | $301,578,000 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.0 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.5271 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.4729 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | Yes (true) | EndowmentsHeldRelatedOrgInd |
| Related Org List Sch R | Yes (true) | RelatedOrgListSchRInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $7,640,445 | OtherCostOrOtherBasisAmt |
| Book Value | $7,640,445 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $1,287,083,876 | OtherCostOrOtherBasisAmt |
| Depreciation | $663,401,638 | DepreciationAmt |
| Book Value | $623,682,238 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $349,882,937 | OtherCostOrOtherBasisAmt |
| Depreciation | $141,546,940 | DepreciationAmt |
| Book Value | $208,335,997 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $468,416,993 | OtherCostOrOtherBasisAmt |
| Depreciation | $394,513,488 | DepreciationAmt |
| Book Value | $73,903,505 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $43,046,584 | OtherCostOrOtherBasisAmt |
| Book Value | $43,046,584 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $956,608,769 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp (5 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| INTEREST IN DANA-FARBER, INC. | $2,249,079,462 |
| RIGHT OF USE - NET OP. LEASES | $369,926,307 |
| RESEARCH RECEIVABLES | $70,854,528 |
| INTEREST IN DFCCN | $48,254,000 |
| MISCELLANEOUS ASSETS | $40,520,722 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $2,778,635,019 | TotalBookValueOtherAssetsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (6 entries)
| DescDesc | AmtAmt |
|---|---|
| OPERATING LEASE LIABILITIES | $393,028,026 |
| RESEARCH ADVANCES | $153,103,942 |
| AMOUNTS DUE 3RD PARTY PAYOR | $66,420,680 |
| MISCELLANEOUS LIABILITIES | $51,101,088 |
| SWAP VALUATION LIABILITY | $21,340,000 |
| PROV FOR MED MALPRACTICE CLAIM | $2,429,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $687,422,736 | TotalLiabilityAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule D, Part V, Line 4 Intended uses of endowment funds | FormAndLineReferenceDesc |
| Explanation | DANA-FARBER, INC. (DFI) A RELATED ORGANIZATION OF DANA-FARBER CANCER INSTITUTE, INC. (DFCI) HOLDS THE ENDOWMENTS FOR DFCI. AS DESCRIBED IN THE CONSOLIDATED AUDITED FINANCIAL STATEMENTS, DFCI'S ENDOWMENTS CONSIST SOLELY OF DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR PURPOSES DIRECTLY RELATED TO DFCI'S EXEMPT MISSION AND PURPOSES. AS REQUIRED BY GENERALLY ACCEPTED ACCOUNTING PRINCIPLES, NEW ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OF DONOR-IMPOSED RESTRICTIONS. ALL USES OF DFCI'S ENDOWMENT FUNDS ARE IN FURTHERANCE OF DFCI'S EXEMPT MISSION AND PURPOSES. | ExplanationTxt |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (11 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| Central America and the Caribbean | 0 | 0 | Program Services | Subcontracted Research | $21,000 |
| Sub-Saharan Africa | 0 | 0 | Program Services | Subcontracted Research | $238,000 |
| Europe (Including Iceland and Greenland) | 0 | 0 | Program Services | Subcontracted Research | $4,143,000 |
| East Asia and the Pacific | 0 | 0 | Program Services | Subcontracted Research | $659,000 |
| South Asia | 0 | 0 | Program Services | Subcontracted Research | $361,000 |
| Middle East and North Africa | 0 | 0 | Program Services | Subcontracted Research | $66,000 |
| South America | 0 | 0 | Program Services | Subcontracted Research | $45,000 |
| North America (Canada Mexico only) | 0 | 0 | Program Services | Subcontracted Research | $957,000 |
| East Asia and the Pacific | 0 | 0 | Program Services | RESEARCH AND EDUCATION | $270,000 |
| Middle East and North Africa | 0 | 0 | Program Services | RESEARCH AND EDUCATION | $24,000 |
| South America | 0 | 0 | Program Services | RESEARCH AND EDUCATION | $161,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $6,945,000 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $6,945,000 | TotalSpentAmt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | Yes (true) | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements | FormAndLineReferenceDesc |
| Explanation | CENTRAL AMERICA AND THE CARIBBEAN-Accrual; EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA MEXICO ONLY)-Accrual; SOUTH AMERICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Phone Solicitations | Yes (X) | PhoneSolicitationsInd |
| In Person Solicitations | Yes (X) | InPersonSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Solicitation Of Govt Grants | Yes (X) | SolicitationOfGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Gross ReceiptsGrossReceiptsAmt | Retained By ContractorRetainedByContractorAmt | Net To OrganizationNetToOrganizationAmt |
|---|---|---|---|---|---|---|---|---|
| Trusense Marketing | ||||||||
| 155 Commerce Dr | Freedom | PA | 15042 | Direct Mail | false | $17,098,713 | $3,009,867 | $14,088,846 |
| Grenzebach Glier Assoc | ||||||||
| 200 South Michican Ave Ste 210 | Chigaco | IL | 60604 | Consulting | false | $80,383 | -$80,383 | |
| Creative Direct Response | ||||||||
| 4200 Parliament Place Third Floor | Lanham | MD | 20706 | Direct Mail | false | $839,020 | -$839,020 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $17,098,713 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $3,929,270 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $13,169,443 | TotalNetToOrganizationAmt |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | ID | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | IA | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | NE | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | SD | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | BMJF WALK | Event1Nm |
| Gross Receipts Event1 | $8,831,242 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $8,666,863 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $164,379 | GrossRevenueEvent1Amt |
| Cash Prizes Event1 | $0 | CashPrizesEvent1Amt |
| Non Cash Prizes Event1 | $0 | NonCashPrizesEvent1Amt |
| Rent Facility Costs Event1 | $115,795 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $48,978 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $0 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $1,354,342 | OtherDirectExpensesEvent1Amt |
| Event2 | DFMC | Event2Nm |
| Gross Receipts Event2 | $8,492,953 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $8,218,043 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $274,910 | GrossRevenueEvent2Amt |
| Cash Prizes Event2 | $0 | CashPrizesEvent2Amt |
| Non Cash Prizes Event2 | $0 | NonCashPrizesEvent2Amt |
| Rent Facility Costs Event2 | $66,345 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $6,848 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $0 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $591,524 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 7 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $5,128,851 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $4,962,884 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $165,967 | GrossRevenueOtherEventsAmt |
| Cash Prizes Other Events | $0 | CashPrizesOtherEventsAmt |
| Non Cash Prizes Other Events | $0 | NonCashPrizesOtherEventsAmt |
| Rent Fclty Costs Other Events | $100,993 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $19,842 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $0 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $673,564 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $22,453,046 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $21,847,790 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $605,256 | GrossRevenueTotalEventsAmt |
| Cash Prizes Total Events | $0 | CashPrizesTotalEventsAmt |
| Non Cash Prizes Total Events | $0 | NonCashPrizesTotalEventsAmt |
| Rent Fclty Costs Total Events | $283,133 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $75,668 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $0 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $2,619,430 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $2,978,231 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$2,372,975 | NetIncomeSummaryAmt |
Schedule H IRS990ScheduleH
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Assistance Policy | Yes (true) | FinancialAssistancePolicyInd |
| Written Policy | Yes (true) | WrittenPolicyInd |
| All Hospitals Policy | Yes (X) | AllHospitalsPolicyInd |
| FPG Reference Free Care | Yes (true) | FPGReferenceFreeCareInd |
| Percent150 | Yes (X) | Percent150Ind |
| FPG Reference Discounted Care | Yes (true) | FPGReferenceDiscountedCareInd |
| Percent300 | Yes (X) | Percent300Ind |
| Free Care Medically Indigent | Yes (true) | FreeCareMedicallyIndigentInd |
| Financial Assistance Budget | Yes (true) | FinancialAssistanceBudgetInd |
| Expenses Exceed Budget | Yes (true) | ExpensesExceedBudgetInd |
| Unable To Provide Care | false | UnableToProvideCareInd |
| Annual Community Bnft Report | Yes (true) | AnnualCommunityBnftReportInd |
| Report Publically Available | Yes (true) | ReportPublicallyAvailableInd |
Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $24,229,822 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $12,972,460 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $11,257,362 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0044 | TotalExpensePct |
Unreimbursed Medicaid UnreimbursedMedicaidGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $121,051,921 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $98,799,025 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $22,252,896 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0087 | TotalExpensePct |
Unreimbursed Costs UnreimbursedCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Total Financial Assistance Typ TotalFinancialAssistanceTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 0 | ActivitiesOrProgramsCnt |
| Persons Served | 0 | PersonsServedCnt |
| Total Community Benefit Expns | $145,281,743 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $111,771,485 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $33,510,258 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0132 | TotalExpensePct |
Community Health Services CommunityHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $6,283,701 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $6,283,701 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0025 | TotalExpensePct |
Health Professions Education HealthProfessionsEducationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $5,837,861 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $983,642 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $4,854,219 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0019 | TotalExpensePct |
Subsidized Health Services SubsidizedHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Research ResearchGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $727,868,537 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $587,954,212 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $139,914,325 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0550 | TotalExpensePct |
Cash And In Kind Contributions CashAndInKindContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $4,296,978 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $4,296,978 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0017 | TotalExpensePct |
Total Other Benefits TotalOtherBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 0 | ActivitiesOrProgramsCnt |
| Persons Served | 0 | PersonsServedCnt |
| Total Community Benefit Expns | $744,287,077 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $588,937,854 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $155,349,223 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0610 | TotalExpensePct |
Total Community Benefits TotalCommunityBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 0 | ActivitiesOrProgramsCnt |
| Persons Served | 0 | PersonsServedCnt |
| Total Community Benefit Expns | $889,568,820 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $700,709,339 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $188,859,481 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0742 | TotalExpensePct |
Physical Imprv And Housing PhysicalImprvAndHousingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $1,958,511 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $1,958,511 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0008 | TotalExpensePct |
Economic Development EconomicDevelopmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Community Support CommunitySupportGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Environmental Improvements EnvironmentalImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Leadership Development LeadershipDevelopmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Coalition Building CoalitionBuildingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Health Improvement Advocacy HealthImprovementAdvocacyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Workforce Development WorkforceDevelopmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $710,700 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $710,700 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0003 | TotalExpensePct |
Other Communtity Building Acty OtherCommuntityBuildingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Net Community Benefit Expns | $0 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0 | TotalExpensePct |
Total Communtity Building Acty TotalCommuntityBuildingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 0 | ActivitiesOrProgramsCnt |
| Persons Served | 0 | PersonsServedCnt |
| Total Community Benefit Expns | $2,669,211 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $0 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $2,669,211 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.0010 | TotalExpensePct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bad Debt Expense Reported | Yes (true) | BadDebtExpenseReportedInd |
| Bad Debt Expense | $12,841,731 | BadDebtExpenseAmt |
| Bad Debt Expense Attributable | $128,417 | BadDebtExpenseAttributableAmt |
| Reimbursed By Medicare | $412,330,734 | ReimbursedByMedicareAmt |
| Cost Of Care Reimbursed By Medcr | $460,015,364 | CostOfCareReimbursedByMedcrAmt |
| Medicare Surplus Or Shortfall | -$47,684,630 | MedicareSurplusOrShortfallAmt |
Costing Methodology Used CostingMethodologyUsedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | Yes (X) | OtherInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Debt Collection Policy | Yes (true) | WrittenDebtCollectionPolicyInd |
| Financial Assistance Prvsn | Yes (true) | FinancialAssistancePrvsnInd |
| Hospital Facilities | 1 | HospitalFacilitiesCnt |
Hospital Facilities HospitalFacilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DANA-FARBER CANCER INSTITUTE INC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 450 BROOKLINE AVE | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02215 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Website Address | WWW.DANA-FARBER.ORG | WebsiteAddressTxt |
| State License | 2335 | StateLicenseNum |
| Licensed Hospital | Yes (X) | LicensedHospitalInd |
| Teaching Hospital | Yes (X) | TeachingHospitalInd |
| Research Facility | Yes (X) | ResearchFacilityInd |
Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp
Hospital Facility Name HospitalFacilityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DANA-FARBER CANCER INSTITUTE INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
| First Licensed CY Or PY | false | FirstLicensedCYOrPYInd |
| Tax Exempt Hospital CY Or PY | false | TaxExemptHospitalCYOrPYInd |
| CHNA Conducted | Yes (true) | CHNAConductedInd |
| Community Definition | Yes (X) | CommunityDefinitionInd |
| Community Demographics | Yes (X) | CommunityDemographicsInd |
| Existing Resources | Yes (X) | ExistingResourcesInd |
| How Data Obtained | Yes (X) | HowDataObtainedInd |
| Community Health Needs | Yes (X) | CommunityHealthNeedsInd |
| Other Health Issues | Yes (X) | OtherHealthIssuesInd |
| Community Hlth Needs Id Process | Yes (X) | CommunityHlthNeedsIdProcessInd |
| Consulting Process | Yes (X) | ConsultingProcessInd |
| Prior CHNA Impact | Yes (X) | PriorCHNAImpactInd |
| CHNA Conducted | 22 | CHNAConductedYr |
| Take Into Account Others Input | Yes (true) | TakeIntoAccountOthersInputInd |
| CHNA Conducted With Other Fclts | false | CHNAConductedWithOtherFcltsInd |
| CHNA Conducted With Non Fclts | false | CHNAConductedWithNonFcltsInd |
| CHNA Report Widely Available | Yes (true) | CHNAReportWidelyAvailableInd |
| Rpt Available On Own Website | Yes (X) | RptAvailableOnOwnWebsiteInd |
| Own Website URL | HTTPS://WWW.DANA-FARBER.ORG/UPLOADEDFILES/PAGES/ABOUT_US/COMMUNITY_OUTREACH/CANCER-CHNA-REPORT-2022. | OwnWebsiteURLTxt |
| Paper Copy Public Inspection | Yes (X) | PaperCopyPublicInspectionInd |
| Implementation Strategy Adopt | Yes (true) | ImplementationStrategyAdoptInd |
| Implementation Strategy Adpt | 22 | ImplementationStrategyAdptYr |
| Strategy Posted Website | Yes (true) | StrategyPostedWebsiteInd |
| Strategy Website URL | HTTPS://WWW.DANA-FARBER.ORG/UPLOADEDFILES/PAGES/ABOUT_US/COMMUNITY_OUTREACH/COMMUNITY-HEALTH-IMPLEME | StrategyWebsiteURLTxt |
| Organization Incur Excise Tax | false | OrganizationIncurExciseTaxInd |
| Elig Criteria Explained | Yes (true) | EligCriteriaExplainedInd |
| FPG Family Incm Lmt Free Dscnt | Yes (X) | FPGFamilyIncmLmtFreeDscntInd |
| FPG Family Incm Lmt Free Care | 150.0 | FPGFamilyIncmLmtFreeCarePct |
| FPG Family Incm Lmt Dscnt Care | 300.0 | FPGFamilyIncmLmtDscntCarePct |
| Medical Indigency Criteria | Yes (X) | MedicalIndigencyCriteriaInd |
| Explained Basis | Yes (true) | ExplainedBasisInd |
| App Financial Asst Expln | Yes (true) | AppFinancialAsstExplnInd |
| Described Info | Yes (X) | DescribedInfoInd |
| Described Suprt Doc | Yes (X) | DescribedSuprtDocInd |
| Provided Hospital Contact | Yes (X) | ProvidedHospitalContactInd |
| Includes Publicity Measures | Yes (true) | IncludesPublicityMeasuresInd |
| FAP Available On Website | Yes (X) | FAPAvailableOnWebsiteInd |
| FAP Available On Website URL | SEE PART VI - SUPPLEMENTAL INFORMATION | FAPAvailableOnWebsiteURLTxt |
| FAP App Available On Website | Yes (X) | FAPAppAvailableOnWebsiteInd |
| FAP App Available On Website URL | SEE PART VI - SUPPLEMENTAL INFORMATION | FAPAppAvailableOnWebsiteURLTxt |
| FAP Summary On Website | Yes (X) | FAPSummaryOnWebsiteInd |
| FAP Summary On Website URL | SEE PART VI - SUPPLEMENTAL INFORMATION | FAPSummaryOnWebsiteURLTxt |
| FAP Avlbl On Request No Charge | Yes (X) | FAPAvlblOnRequestNoChargeInd |
| FAP App Avlbl On Request No Chrg | Yes (X) | FAPAppAvlblOnRequestNoChrgInd |
| FAP Sum Avlbl On Request No Chrg | Yes (X) | FAPSumAvlblOnRequestNoChrgInd |
| Notified FAP Copy Bill Display | Yes (X) | NotifiedFAPCopyBillDisplayInd |
| Communtity Notified FAP | Yes (X) | CommuntityNotifiedFAPInd |
| FAP Translated | Yes (X) | FAPTranslatedInd |
| FAP Actions On Nonpayment | Yes (true) | FAPActionsOnNonpaymentInd |
| Permit No Actions | Yes (X) | PermitNoActionsInd |
| Collection Activities | false | CollectionActivitiesInd |
| Provided Written Notice | Yes (X) | ProvidedWrittenNoticeInd |
| Made Effort Orally Notify | Yes (X) | MadeEffortOrallyNotifyInd |
| Processed FAP Application | Yes (X) | ProcessedFAPApplicationInd |
| Nondis Emergency Care Policy | Yes (true) | NondisEmergencyCarePolicyInd |
| Look Back Medicaid Medcr Prvt | Yes (X) | LookBackMedicaidMedcrPrvtInd |
| Amounts Generally Billed | false | AmountsGenerallyBilledInd |
| Gross Charges | false | GrossChargesInd |
Supplemental Information SupplementalInformationGrp (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule H, Part V, Section B, Line 5 Facility , 1 | Facility , 1 - DFCI. IN 2022, DANA-FARBER'S BOARD OF TRUSTEES APPROVED THE 2022-2025 CANCER-FOCUSED COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) AND IMPLEMENTATION PLAN TO ENSURE THAT OUR COLLECTIVE EFFORTS HAVE THE MAXIMUM POSSIBLE IMPACT WITHIN THE INSTITUTE'S PRIORITY NEIGHBORHOODS. DANA-FARBER'S COMMUNITY BENEFITS OFFICE RETAINED HEALTH RESOURCES IN ACTION (HRIA), A NON-PROFIT PUBLIC HEALTH CONSULTANCY ORGANIZATION IN BOSTON, TO UNDERTAKE A COMPREHENSIVE ASSESSMENT OF THE HEALTH NEEDS WITHIN OUR PRIORITY COMMUNITIES, INCLUDING HOW THOSE NEEDS ARE CURRENTLY BEING ADDRESSED AND WHERE THERE ARE OPPORTUNITIES TO ADDRESS THESE NEEDS IN THE FUTURE. DANA-FARBER'S 2022-2025 CHNA BUILDS OFF PREVIOUS EFFORTS TO GAIN A GREATER UNDERSTANDING OF THE HEALTH ISSUES FACING BOSTON RESIDENTS ACROSS THE CONTINUUM OF CANCER CARE, WITH A FOCUS ON THE CITY OF BOSTON AND DANA-FARBER'S PRIORITY NEIGHBORHOODS FOR COMMUNITY BENEFITS WORK - DORCHESTER, ROXBURY, MISSION HILL, JAMAICA PLAIN, AND MATTAPAN. THE CHNA INTEGRATES KEY FINDINGS FROM THE CITYWIDE CHNA AND DELVES MORE DEEPLY INTO THE NEEDS AND EXPERIENCES OF CANCER PATIENTS, SURVIVORS, AND CAREGIVERS THROUGHOUT THE CANCER CONTINUUM, EXPLORING BEHAVIORS AND HEALTH OUTCOMES AROUND PREVENTION, SCREENING, TREATMENT, AND SURVIVORSHIP USING SOCIAL DETERMINANTS OF HEALTH AND HEALTH EQUITY FRAMEWORKS. THE ONGOING COVID-19 PANDEMIC, WHICH HAS RESULTED IN SIGNIFICANT CHANGES AND INEQUITIES IN HEALTH, THE ECONOMY, AND THE WORKFORCE, HAS BEEN AN IMPORTANT AND EVOLVING BACKDROP TO THIS CHNA. THE PURPOSE OF THE CHNA IS TO ADVANCE COMMUNITY EFFORTS AND PRIORITY AREAS BY: ASSESSING CANCER BURDEN IN THE COMMUNITY AS WELL AS ACCESS TO AND AVAILABILITY OF CANCER-RELATED SERVICES; IDENTIFYING KEY AREAS OF SIGNIFICANT COMMUNITY NEED AND VULNERABLE POPULATIONS; EXAMINING THE IMPACT AND ROLE OF SOCIAL DETERMINANTS OF HEALTH; AND FACILITATING THE DEVELOPMENT OF MULTI-YEAR IMPLEMENTATION STRATEGIES TO GUIDE THE HOSPITALS' COMMUNITY HEALTH INITIATIVES AND COMMUNITY INVESTMENTS. IN ADDITION TO IDENTIFYING BROAD HEALTH ISSUES FACING RESIDENTS, THE 2022-2025 CHNA INVESTIGATES THE FULL CONTINUUM OF CANCER CARE; IT EXPLORES DIFFERENT ASPECTS OF CARE FROM INITIAL SCREENING TO TREATMENT AND CULMINATES WITH CONSIDERATIONS OF SURVIVORSHIP. THE BOSTON CHNA-CHIP COLLABORATIVE (THE COLLABORATIVE) WAS CREATED AND LAUNCHED BY SEVERAL STAKEHOLDERS-COMMUNITY ORGANIZATIONS, HEALTH CENTERS, COMMUNITY DEVELOPMENT CORPORATIONS, HOSPITALS, AND THE BOSTON PUBLIC HEALTH COMMISSION. IN 2019, THE COLLABORATIVE CONDUCTED THE FIRST LARGE-SCALE COLLABORATIVE CITYWIDE COMMUNITY HEALTH NEEDS ASSESSMENT (BOSTON CHNA) AND COMMUNITY HEALTH IMPROVEMENT PLANNING (BOSTON CHIP) PROCESS. THE GOALS OF THE BOSTON CHNA ARE TO SYSTEMATICALLY IDENTIFY THE HEALTH-RELATED NEEDS, STRENGTHS, AND RESOURCES OF COMMUNITIES TO INFORM FUTURE PLANNING, UNDERSTAND THE CURRENT HEALTH STATUS OF BOSTON OVERALL AND ITS SUB-POPULATIONS WITHIN THEIR SOCIAL CONTEXT, AND MEET REGULATORY REQUIREMENTS FOR SEVERAL INSTITUTIONS, ORGANIZATIONS, AND AGENCIES (E.G. IRS REQUIREMENTS FOR NON-PROFIT HOSPITALS, PUBLIC HEALTH ACCREDITATION BOARD FOR HEALTH DEPARTMENTS). DURING THE CITYWIDE CHNA: AS A MEMBER OF THE STEERING COMMITTEE, DANA-FARBER WORKED CLOSELY WITH MEMBERS OF THE COLLABORATIVE TO CONDUCT A ROBUST DATA COLLECTION AND A COMMUNITY ENGAGEMENT PROCESS. THE COVID-19 PANDEMIC PLAYED AN IMPORTANT BACKDROP DURING THE ASSESSMENTS PHASE. THE 2022 CHNA'S ALSO EXPLORED HOW THE PANDEMIC AND RACIAL INJUSTICES HAVE AFFECTED COMMUNITY HEALTH NEEDS. DANA-FARBER IS COMMITTED TO MEETING THE HEALTH NEEDS OF MEDICALLY UNDERSERVED POPULATIONS AND RECOGNIZES THAT MANY OF THE POPULATIONS THAT DANA-FARBER FOCUSED ON IN ITS 2022 CHNA HAVE BEEN DISPROPORTIONATELY IMPACTED BY THE COVID-19 PANDEMIC. GIVEN THE UNPRECEDENTED NATURE OF THE COVID-19 PANDEMIC, IT IS CRITICAL NOW, MORE THAN EVER, TO UNDERSTAND COMMUNITY NEEDS, EXPERIENCES, AND OPPORTUNITIES FOR THE FUTURE. SECONDARY DATA FOR THIS REPORT COME FROM A VARIETY OF SOURCES. DATA SOURCES INCLUDE THE BOSTON BEHAVIORAL RISK FACTOR SURVEILLANCE SURVEY (BBRFSS), THE U.S. CENSUS, THE MASSACHUSETTS CANCER REGISTRY, AND VITAL RECORDS. AS PART OF THE BBRFSS, A SEPARATE COVID-19 HEALTH EQUITY SURVEY WAS CONDUCTED IN DECEMBER 2020/JANUARY 2021 BY THE BOSTON PUBLIC HEALTH COMMISSION TO BETTER UNDERSTAND EXPERIENCES AMONG RESIDENTS WHO HAVE BEEN MOST IMPACTED BY THE PANDEMIC. DATA FROM THIS COVID-19 HEALTH EQUITY SURVEY ARE ALSO INCLUDED IN THIS REPORT. THE RESEARCH AND EVALUATION OFFICE AT THE BOSTON PUBLIC HEALTH COMMISSION CONDUCTED THE DATA ANALYSIS FOR NEARLY ALL THE SECONDARY DATA ON HEALTH INDICATORS IN THIS REPORT (E.G., LIFESTYLE BEHAVIORS, SCREENING BEHAVIORS, CANCER INCIDENCE, CANCER MORTALITY). ANALYSES ARE PRESENTED AS FREQUENCIES (PERCENTAGES) AND RATES THROUGHOUT THE REPORT. ADDITIONAL DATA SOURCES INCLUDE PRESENTATIONS AND REPORTS REGARDING THE SOCIAL DETERMINANTS OF HEALTH, HEALTH OUTCOMES, AND HEALTH CARE EXPERIENCES FOR SEVERAL COMMUNITIES OF COLOR AND SEXUAL AND GENDER MINORITY POPULATIONS. THESE SOURCES INCLUDE: A 2022 PRESENTATION BY DR. DON S. DIZON, "DON'T ASK, CAN'T COUNT. ADDRESSING THE INVISIBILITY OF THE SGM COMMUNITY ACROSS THE CANCER TRAJECTORY EXPERIENCE FENWAY HEALTH AND BLACK BOSTON COVID-19 COALITION 2022 REPORT, "LEARNING FROM BOSTON'S BLACK COMMUNITY WHAT SUPPORTS ITS HEALTH, RESILIENCE, AND WELLBEING" (REFERRED TO HEREAFTER AS THE "BLACK BOSTON 2022 REPORT"); AND THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH'S WOMEN'S HEALTH NETWORK 2019 REPORT, "ASSESSMENT OF COLORECTAL CANCER SCREENING ATTITUDES AND PRACTICES AMONG THE ASIAN COMMUNITY IN MASSACHUSETTS." |
| Schedule H, Part V, Section B, Line 5 Facility , 2 | Facility , 2 - DFCI. DANA-FARBER DESIGNED A QUALITATIVE KEY INFORMANT SURVEY. THIS SURVEY WAS FIELDED WITH CANCER SURVIVORS AND REPRESENTATIVES FROM ORGANIZATIONS THAT SERVE INDIVIDUALS ACROSS THE CANCER CONTINUUM. THE SURVEY AIMED TO UNDERSTAND THEIR EXPERIENCES WITH CANCER PREVENTION, CANCER CARE, AND SURVIVORSHIP; RECOMMENDATIONS FOR CANCER AND CHRONIC DISEASE PREVENTION SERVICES AND RESOURCES; THE INFLUENCE OF THE COVID-19 PANDEMIC ON ACCESS TO CANCER SCREENING AND HEALTH CARE; POTENTIAL FACILITATORS TO INCREASE CANCER SCREENING; AND RECOMMENDATIONS FOR ADDRESSING GAPS IN SERVICES AND RESOURCES FOR CANCER SURVIVORS. OF 27 PEOPLE CONTACTED, A TOTAL OF 13 CANCER SURVIVORS AND COMMUNITY STAKEHOLDERS REPRESENTING COMMUNITY-BASED, PUBLIC HEALTH, AND HEALTH CARE ORGANIZATIONS COMPLETED THIS QUALITATIVE SURVEY. DFCI WORKED WITH A VARIETY OF PARTNERS TO GATHER PRIMARY QUALITATIVE DATA THROUGH FOCUS GROUPS AND INTERVIEW DISCUSSIONS. DFCI MADE A CONCERTED EFFORT TO ENGAGE WITH POPULATIONS AND COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED. ALTOGETHER, 8 FOCUS GROUPS WITH 69 PARTICIPANTS (CAREGIVERS, PATIENTS/SURVIVORS) AND 4 INTERVIEW DISCUSSIONS WERE CONDUCTED SPECIFICALLY FOR ITS CHNA. KEY THEMES FROM TWO ADDITIONAL DATA SOURCES WERE ALSO ANALYZED AND ARE INCORPORATED INTO THIS CHNA. FIRST, THE BOSTON BREAST CANCER EQUITY COALITION (BBCEC) SHARED KEY THEMES FROM 9 INTERVIEWS CONDUCTED WITH SMALL, LOCAL NON-PROFIT ORGANIZATIONS WHO SUPPORT BIPOC COMMUNITIES. SECOND, THE BOSTON PUBLIC HEALTH COMMISSION ALSO SHARED KEY FINDINGS FROM A FOCUS GROUP CONDUCTED WITH THEIR 10-MEMBER RACIAL HEALTH EQUITY ADVISORY COMMITTEE (RHEAC) TO GARNER INPUT TO INFORM THE CREATION OF A LUNG CANCER COMMUNICATION CAMPAIGN. THIS REPORT ALSO INTEGRATES FINDINGS FROM DATA COLLECTED AS PART OF THE 2022 BOSTON CHNA-CHIP COLLABORATIVE'S PROCESS. THE COLLABORATIVE'S COMMUNITY ENGAGEMENT WORK GROUP FACILITATED 29 VIRTUAL AND IN-PERSON FOCUS GROUP DISCUSSIONS WITH A TOTAL OF 309 RESIDENTS WHO HAVE BEEN DISPROPORTIONATELY BURDENED BY SOCIAL, ECONOMIC, AND HEALTH CHALLENGES INCLUDING: YOUTH AND ADOLESCENTS, OLDER ADULTS, PERSONS WITH DISABILITIES, LOW-RESOURCED INDIVIDUALS AND FAMILIES, LGBTQIA+ POPULATIONS, RACIALLY/ETHNICALLY DIVERSE POPULATIONS (E.G., AFRICAN AMERICAN, LATINO, HAITIAN, CAPE VERDEAN, VIETNAMESE, CHINESE), LIMITED-ENGLISH SPEAKERS, IMMIGRANT AND ASYLEE COMMUNITIES, FAMILIES AFFECTED BY INCARCERATION AND/OR VIOLENCE, AND VETERANS. SOME FOCUS GROUPS WERE CONDUCTED IN LANGUAGES OTHER THAN ENGLISH, INCLUDING SPANISH, CHINESE, AND VIETNAMESE. COLLABORATIVE MEMBERS ALSO CONDUCTED KEY INFORMANT INTERVIEWS WITH 62 INDIVIDUALS. THESE INTERVIEWEES INCLUDED LEADERS AND STAFF FROM PUBLIC HEALTH, HEALTH CARE, BEHAVIORAL HEALTH, THE FAITH COMMUNITY, IMMIGRANT SERVICES, HOUSING ORGANIZATIONS, ECONOMIC DEVELOPMENT, COMMUNITY DEVELOPMENT, RACIAL JUSTICE ORGANIZATIONS, SOCIAL SERVICE ORGANIZATIONS, EDUCATION, COMMUNITY COALITIONS, THE BUSINESS COMMUNITY, CHILDCARE CENTERS, ELECTED GOVERNMENT OFFICES, AND OTHERS. THE STRATEGIES AND GOALS OUTLINED IN OUR 2022-2025 CHNA IMPLEMENTATION PLAN ARE A NATURAL CONTINUATION OF THE EFFORTS IDENTIFIED IN OUR 2020-2023 PLAN AND ARE DESIGNED TO ADVANCE AND STRENGTHEN OUR EXISTING COMMUNITY-BASED INITIATIVES WHILE ALSO SEEKING TO ADDRESS THE SOCIAL DETERMINANTS OF HEALTH THROUGH COLLABORATIVE PARTNERSHIPS. |
| Schedule H, Part V, Section B, Line 11 Facility , 1 | Facility , 1 - DFCI. DANA-FARBER CANCER INSTITUTE CAPTURED AND ADDRESSED ALL THE NEEDS IDENTIFIED IN THE COMMUNITY HEALTH NEEDS ASSESSMENT AND THE ACCOMPANYING IMPLEMENTATION PLAN. A FULL DESCRIPTION OF OUR PROGRAMS IS AVAILABLE ON OUR WEBSITE BOTH IN THE COMMUNITY HEALTH NEEDS ASSESSMENT REPORT AND IN THE COMMUNITY HEALTH IMPLEMENTATION PLAN. CANCER REMAINS A LEADING CAUSE OF DEATH IN BOSTON. WHILE THE CHNA FINDINGS INDICATE THAT COLLECTIVE EFFORTS TO ADVANCE CANCER SCREENING AND PREVENTION ARE MAKING A DIFFERENCE, THE OVERALL BURDEN OF CANCER ACROSS ALL TYPES IS SIGNIFICANT AND MORE EFFORT IS NEEDED TO REDUCE THE CANCER BURDEN AND ADDRESS DISPARITIES. DANA-FARBER RECOGNIZES THAT OUR EFFORTS MUST GO BEYOND CANCER CARE AND TREATMENT, AND AS SUCH, WE WILL CONTINUE OUR UNWAVERING COMMITMENT TO REDUCING THE CANCER BURDEN AND PROMOTING SURVIVORSHIP. WE REMAIN COMMITTED TO EDUCATING THE COMMUNITY AND RAISING AWARENESS ABOUT THE IMPORTANCE OF CANCER PREVENTION, OUTREACH, SCREENING, EARLY DETECTION, CLINICAL TRIALS AND SURVIVORSHIP. IN ADDITION, WE WILL CONTINUE TO CONDUCT A BROAD SCOPE OF COMMUNITY-BASED RESEARCH AND EVIDENCE-BASED INTERVENTIONS THROUGH COLLABORATIVE WORK IN LOCAL NEIGHBORHOODS AND THROUGHOUT THE REGION. OUR EXPERTISE AS A COMPREHENSIVE CANCER CENTER LEADS US TO FOCUS LARGELY ON REDUCING CANCER INCIDENCE AND MORTALITY AMONG MEDICALLY UNDERSERVED POPULATIONS THROUGH OUR CLINICAL COMMUNITY SCREENING AND OUTREACH PROGRAMS, WHICH INCLUDE MOBILE MAMMOGRAPHY AND BREAST HEALTH EDUCATION, SKIN CANCER EDUCATION AND SCREENING, HPV EDUCATION AND VACCINATION, TOBACCO CESSATION AND INCREASING AWARENESS ABOUT SURVIVORSHIP IN COMMUNITIES OF COLOR. WE RECOGNIZE THAT OUR PRIORITY NEIGHBORHOODS ARE ALSO DEALING DISPROPORTIONATELY WITH CHALLENGING SITUATIONS RELATED TO SOCIAL AND ECONOMIC FACTORS, SUCH AS LIMITED EMPLOYMENT OPPORTUNITIES, SUBSTANCE ABUSE AND OPIOID ADDICTION, LOW EDUCATION LEVELS, LACK OF AFFORDABLE HOUSING, AND COMMUNITY VIOLENCE. WE WORK ON THESE BROADER ISSUES BY ADVOCATING AND BY PARTNERING WITH LOCAL COALITIONS AND COMMUNITY-BASED ORGANIZATIONS SUCH AS THE MASS HEALTH EQUITY COMPACT LED BY THE MASSACHUSETTS LEAGUE OF COMMUNITY HEALTH CENTERS. SIGNIFICANT PROGRESS HAS BEEN MADE IN ADVANCING THE GOALS SET IN OUR 2020-2023 CHNA IMPLEMENTATION PLAN. SUMMARIZED BELOW ARE EXAMPLES OF KEY ACCOMPLISHMENTS FROM THE PAST THREE YEARS, WHICH DEMONSTRATE THE COLLECTIVE IMPACT OF OUR WORK. OUR IMPACT IS GREATLY STRENGTHENED BY EMBEDDING PROGRAMMING AND SERVICES INTO THE FABRIC OF THE COMMUNITIES WE SERVE. * LAUNCHED NEW STATE OF THE ART MOBILE MAMMOGRAPHY VAN EQUIPPED WITH NEW TOMOSYNTHESIS IMAGING TECHNOLOGY. * PROVIDED 4,029 MAMMOGRAMS ON DANA-FARBER'S MAMMOGRAPHY VAN AND 1,735 MAMMOGRAMS AT DANA-FARBER'S MAMMOGRAPHY SUITE AT WHITTIER STREET HEALTH CENTER IN ROXBURY. * SUCCESSFULLY LAUNCHED NEW COMMUNITY-FACING PATIENT NAVIGATION PROGRAM, WHICH WAS PILOTED IN THE BREAST, THORACIC, AND GASTROINTESTINAL DISEASE CENTERS AND WILL BE EMBEDDED INTO ALL MAJOR CLINICAL AREAS AT DANA-FARBER. * AWARDED THE FIRST ROUND OF FUNDING FOR DANA-FARBER'S ACCESS TO SERVICES GRANTS TO 12 NONPROFIT ORGANIZATIONS IN GREATER BOSTON AND COMMITTED $1 MILLION DOLLARS TO THE HEALTHY NEIGHBORHOODS EQUITY FUND TO ADDRESS HOUSING NEEDS IN GREATER BOSTON. * COMMITTED $500K TO HEALTHY RETAIL COMMERCE FUND TO SUPPORT HEALTHY FOOD ACCESS AND $250K TO THE BOSTON LOCAL INITIATIVES SUPPORT CORPORATION (LISC BOSTON) SMALL BUSINESS GROWTH FUND TO SUPPORT ECONOMIC EMPOWERMENT AND GROW BUSINESSES OWNED BY BLACK, LATINO, AND INDIGENOUS ENTREPRENEURS AND OTHER PEOPLE OF COLOR. * CONTINUED TO PROVIDE STREAMLINED DIAGNOSIS, TREATMENT, AND EDUCATION FOR MEDICALLY UNDERSERVED PATIENTS WITH SUSPECTED MALIGNANCIES THROUGHOUT THE CONTINUUM OF CARE THROUGH DANA-FARBER'S CANCER CARE EQUITY PROGRAM (CCEP) AT FEDERALLY QUALIFIED COMMUNITY HEALTH CENTERS. O SINCE PROGRAM INCEPTION IN 2012, THE PROGRAM HAS SEEN OVER 692 PATIENTS AS NEW CONSULTS AND 507 PATIENTS IN FOLLOW-UP VISITS. * PROVIDED 348 INDIVIDUAL TOBACCO CESSATION COUNSELING SESSIONS TO 126 PATIENTS. O 104 PARTICIPANTS (84%) REPORTED THAT THEY WERE ABLE TO REDUCE THEIR TOTAL NUMBER OF CIGARETTES SMOKED PER DAY, AND 37 (28%) REPORTED BEING ABLE TO QUIT COMPLETELY. O PROVIDED NICOTINE REPLACEMENT THERAPY (NICOTINE PATCHES AND LOZENGES) AND GIFT CARDS TO 49 GIFT PATIENTS ENROLLED IN THE SMOKING CESSATION PROGRAM TO ENCOURAGE INDIVIDUALS TO REDUCE THEIR TOBACCO USAGE AND QUIT SMOKING. * ENGAGED 2,233 RESIDENTS IN SUN SAFETY EDUCATION AND SKIN CANCER SCREENING. O MADE CALLS TO 264 PARTICIPANTS FOR FOLLOW-UP, WITH 128 REFERRED FOR BIOPSY. * CONTINUED TO LEAD STATEWIDE MASSACHUSETTS HPV COALITION IN PARTNERSHIP WITH TEAM MAUREEN. O LAUNCHED UPDATED DENTAL TOOLKIT, AVAILABLE IN 7 LANGUAGES O CONVENED APPROXIMATELY 250 MEDICAL AND DENTAL PROVIDERS, PUBLIC HEALTH PROFESSIONALS, AND COMMUNITY ADVOCATES THROUGH ANNUAL HPV-RELATED CANCER SUMMIT TO DISSEMINATE LATEST RESEARCH AND BEST PRACTICES. * PARTNERED WITH UNION CAPITAL BOSTON AND THE DANA-FARBER/HARVARD CANCER CENTER TO ENGAGE OVER 800 COMMUNITY RESIDENTS THROUGH VIRTUAL EDUCATION NIGHTS FOCUSED ON CANCER PREVENTION TOPICS. DANA-FARBER CANCER INSTITUTE |COMMUNITY HEALTH IMPLEMENTATION PLAN 9. * LAUNCHED A NEW PARTNERSHIP WITH MYHEALTHFAIR.ORG TO INCREASE VIRTUAL EDUCATION AND OUTREACH WITH THE LOCAL SPANISH-SPEAKING COMMUNITY. |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 9 | FacilityNum |
Oth Hlth Care Fclts Not Hospital OthHlthCareFcltsNotHospitalGrp
Oth Hlth Care Fclts OthHlthCareFcltsGrp (9 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | FacilityFacilityTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|
| DFBWCC AT SOUTH SHORE HOSPITAL | |||||
| 101 COLUMBIAN STREET | SOUTH WEYMOUTH | MA | 02190 | SATELLITE | |
| DFBWCC AT MILFORD REGIONAL MED CNTR | |||||
| 20 PROSPECT STREET | MILFORD | MA | 01757 | SATELLITE | |
| DFCI - CHESTNUT HILL | |||||
| 300 BOYLSTON STREET | NEWTON | MA | 02459 | SATELLITE | |
| DFCI - MERRIMACK VALLEY | |||||
| 5 BRANCH STREET | METHUEN | MA | 01844 | SATELLITE | |
| DFNH ONCOLOGY-HEMATOLOGY | |||||
| ELLIOTT MED CENTER 40 BUTTRICK RD S | LONDONDERRY | NH | 03053 | SATELLITE | TE B |
| DFCI AT ST ELIZABETH'S MEDICAL CNTR | |||||
| CUSHING PAVILION 736 CAMBRIDGE STRE | BRIGHTON | MA | 02135 | SATELLITE | ET |
| DFCI - LIBBEY PARK | |||||
| 51 PERFORMANCE DRIVE | WEYMOUTH | MA | 02189 | SATELLITE | |
| DFCI - MOBILE MAMMOGRAPHY SERVICE | |||||
| 450 BROOKLINE AVENUE | BOSTON | MA | 02215 | SATELLITE | |
| DFCI - WHITTIER STREET HEALTH CENTER | |||||
| 1290 TREMONT STREET | ROXBURY | MA | 02120 | SATELLITE | |
Supplemental Information Detail SupplementalInformationDetail (24 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule H, Part I, Line 3c | IN ADDITION TO DETERMINING ELIGIBILITY FOR DISCOUNTED CARE BASED ON FAMILY INCOME, DFCI OFFERS ASSISTANCE TO PATIENTS WHO HAVE EXCESSIVE MEDICAL BILLS (EXCEEDING 30-40% OF FAMILY INCOME). |
| Schedule H, Part I, Line 6a | THE COMMUNITY BENEFIT REPORT WAS COMPLETED BY DFCI AND IS ANNUALLY PROVIDED TO THE MASSACHUSETTS ATTORNEY GENERAL'S OFFICE, WHERE IT IS THEN MADE PUBLIC ON ITS WEBSITE. |
| Schedule H, Part I, Line 7 | DFCI'S STATE COST REPORT WAS USED TO DEVELOP THE INSTITUTE'S COST TO CHARGE RATIO THAT WAS APPLIED TO CHARITY CARE CHARGES TO DETERMINE THE COST OF FINANCIAL ASSISTANCE (LINE 7A). LINE 7B REFLECTS THE SPECIFIC LOSS INCURRED FOR THE INSTITUTE'S MEDICAID ACTIVITY. THE INSTITUTE IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTE TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER. THE AMOUNT REPORTED AS HEALTH TRAINING REPRESENT COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. DEPARTMENT LEADERS SUBMIT EXPENDITURES TO COMMUNITY BENEFITS ALONG WITH A DESCRIPTION OF THE SERVICES PROVIDED TO MEDICALLY UNDERSERVED POPULATIONS. LINE 7F EXPENDITURES ARE REVIEWED BY LEADERSHIP AND IN PARTNERSHIP WITH DFCI'S OFFICE OF FINANCE, THE EXPENDITURES ARE APPROVED. THE AMOUNTS ARE CAPTURED IN THREE BUCKETS - CB EXPENDITURES (ALL PROGRAMS); LEVERAGED FUNDS (THOSE FUNDS SUPPORTED IN FULL OR PART THROUGH GRANTS/DONATIONS) AND COMMUNITY SPONSORSHIPS. |
| Schedule H, Part II, Line 1 | PHYSICAL IMPROVEMENTS AND HOUSING - DFCI PROVIDES A LIMITED NUMBER OF LOW COST ROOMS THAT SERVE AS A HOME AWAY FROM HOME FOR ONCOLOGY PATIENTS AND THEIR FAMILIES WHILE THEY ARE RECEIVING TREATMENT. |
| Schedule H, Part II, Line 8 | WORKFORCE DEVELOPMENT: IN 2022, DANA-FARBER LAUNCHED A NEW PROGRAM WITH MASSASOIT COMMUNITY COLLEGE CREATING A PIPELINE PROGRAM FOR CLINICAL ASSISTANT POSITIONS WITHIN NURSING AND PATIENT CARE SERVICES. MASSASOIT'S MEDICAL ASSISTANT PROGRAM INCLUDES TRAINING IN CLINICAL DUTIES SUCH AS OBTAINING MEDICAL HISTORIES, RECORDING VITAL SIGNS, PREPARING PATIENTS FOR EXAMINATIONS PERFORMING EKG'S, AND PHLEBOTOMY TO NAME A FEW. IN FY22 THE CLINICAL ASSISTANT PIPELINE PROGRAM HOSTED 2 INTERNS AND UPON THE SUCCESSFUL COMPLETION OF THEIR INTERNSHIP, WERE HIRED INTO FULL TIME ROLES. DANA-FARBER CONTINUES TO PARTNER WITH JEWISH VOCATIONAL SERVICES IN CREATING PIPELINES TO CAREERS IN PHARMACY. THE PHARMACY TECH PIPELINE PROGRAM HOSTED 4 INTERNS IN 2022. THREE OF THE FOUR INTERNS WERE HIRED INTO FULL-TIME PHARMACY TECH POSITION AT DANA-FARBER. STUDENT TRAINING PROGRAMS: TO ENCOURAGE UNDERREPRESENTED MINORITY (URM) STUDENTS TO EXPLORE AND PURSUE CAREERS IN HEALTH AND SCIENCE, DANA-FARBER MAINTAINS EDUCATIONAL PARTNERSHIPS WITH BOSTON AREA HIGH SCHOOLS, COLLEGES, AND UNIVERSITIES. DANA-FARBER HIRES UPWARD OF 70 STUDENTS THROUGHOUT THE SCHOOL YEAR AND SUMMER. DURING THE ACADEMIC YEAR 2021-2022, 22 PAID INTERNS SUPPORTED RESEARCH AND PATIENT CARE DEPARTMENTS IN A MEANINGFUL WAY AND PARTICIPATED IN ADDITIONAL PROGRAMMING FOCUSED ON COLLEGE AND CAREER READINESS. DURING THE SUMMER OF 2022, DANA-FARBER HIRED 60 BOSTON HIGH SCHOOL AND COLLEGE STUDENTS INTO DEPARTMENT-BASED INTERNSHIPS. STUDENTS' PLACEMENTS WERE EITHER FULLY ONSITE, HYBRID, OR FULLY REMOTE. IN ADDITION TO THE JOB EXPERIENCES, STUDENTS PARTICIPATED IN VIRTUAL PROFESSIONAL DEVELOPMENT, COLLEGE READINESS, AND LIFE SKILLS WORKSHOPS. ELIGIBLE STUDENTS EITHER ATTENDED OR GRADUATED FROM BOSTON PUBLIC SCHOOLS. THE PROGRAM SUCCESSFULLY RETAINED 100% OF STUDENTS. DANA-FARBER ACTIVELY PARTICIPATES IN SCHOOL-TO-CAREER PROGRAMS WITH THE BOSTON PRIVATE INDUSTRY COUNCIL (PIC). ONE PROGRAM INCLUDES GROUNDHOG JOB SHADOW DAY, WHERE HIGH SCHOOL STUDENTS SHADOW DANA-FARBER EMPLOYEES LEARNING ABOUT CAREERS IN HEALTHCARE AND SPECIFIC JOB RESPONSIBILITIES, AS WELL AS THE SKILLS AND TRAINING NEEDED FOR THE POSITION. FY22, JOB SHADOW DAY WAS CANCELED DUE TO COVID. DANA-FARBER STAFF ALSO PARTICIPATES IN SCHOOL-BASED EVENTS INCLUDING FENWAY HIGH SCHOOL'S ANNUAL CAREER FAIR. IN FY22, 7 DFCI STAFF VOLUNTEERS LENT THEIR EXPERTISE IN MOCK INTERVIEWS AND SERVED ON CAREER PANELS. THE DANA-FARBER SUMMER ADMINISTRATIVE INTERNSHIP PROGRAM IS ANOTHER STUDENT TRAINING PROGRAM FOR UNDERGRADUATE RISING SENIORS AND GRADUATE STUDENTS. THIS PROGRAM IS DESIGNED TO INCREASE THE TALENT PIPELINE FOR MANAGEMENT LEVEL POSITIONS AND ATTRACT TALENT THAT ADDS TO THE INSTITUTE'S DIVERSITY. THE 10-WEEK SUMMER PROGRAM ENGAGES INTERNS IN PROJECT WORK, PROFESSIONAL DEVELOPMENT, AND MENTORSHIP WORKING ALONGSIDE EXECUTIVE LEADERS. OVER THE LAST FOUR SUMMERS, 41 INTERNS COMPLETED THE PROGRAM. TO DATE, TEN PARTICIPANTS HAVE BEEN HIRED INTO POSITIONS AT DANA-FARBER. IN SUMMER 2022, A NEW COLLABORATION WITH THE UNITED NEGRO COLLEGE FUND (UNCF) ERNEST E. LIFE SCIENCES PROGRAM WAS ESTABLISHED. UNCF PARTNERS WITH HISTORICALLY BLACK COLLEGES AND UNIVERSITIES AND PLACES STUDENTS INTO PAID INTERNSHIP OPPORTUNITIES AT BOSTON'S LIFE SCIENCE AND HEALTHCARE COMPANIES. DANA-FARBER HOSTED OUR FIRST UNCF INTERN AND PLAN TO CONTINUE GROWING THIS PARTNERSHIP. IN FY22, WE SERVED 48 HIGH SCHOOL STUDENTS OF WHICH 96% ARE URM, 16 COLLEGE STUDENTS OF WHICH 81% ARE URM AND 81% ARE STEM OR HEALTH SCIENCES MAJORS, AND 11 GRADUATE INTERNS OF WHICH 36% ARE URM. |
| Schedule H, Part V SECTION A D | DFCI'S MAIN CAMPUS IS AT 450 BROOKLINE AVE., BOSTON, MA, 02115. DFCI'S SATELLITE LOCATIONS (BELOW) EACH OPERATE UNDER THE SAME HOSPITAL LICENSE. DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER AT MILFORD HOSPITAL, 20 PROSPECT STREET, MILFORD, MA 01757 DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER AT SOUTH SHORE HOSPITAL, 101 COLUMBIAN STREET, SOUTH WEYMOUTH, MA 02190 DANA-FARBER AT ST. ELIZABETH'S MEDICAL CENTER, 736 CAMBRIDGE STREET, CUSHING PAVILION, 5TH FLOOR, BRIGHTON, MA 02135 DANA-FARBER CANCER INSTITUTE CHESTNUT HILL, 300 BOYLSTON STREET, NEWTON, MA 02459 DANA-FARBER CANCER INSTITUTE - MERRIMACK VALLEY, 5 BRANCH STREET, METHUEN, MA 01844 DANA-FARBER CANCER INSTITUTE FOXBOROUGH, 22 PATRIOT PLACE, FOXBOROUGH, MA, 02035 DANA-FARBER CANCER INSTITUTE - LIBBEY PARK, 51 PERFORMANCE DRIVE, WEYMOUTH, MA 02189 DANA-FARBER CANCER INSTITUTE - MOBILE MAMMOGRAPHY SERVICE, 450 BROOKLINE AVENUE, BOSTON, MA 02215 DANA-FARBER CANCER INSTITUTE - WHITTIER STREET HEALTH CENTER, 1290 TREMONT STREET, ROXBURY, MA 02120 DANA-FARBER/NEW HAMPSHIRE ONCOLOGY HEMATOLOGY ALSO OPERATES A CLINICAL LOCATION AT 40 BUTTRICK ROAD, SUITE B, LONDONDERRY, NH 03053. |
| Schedule H, Part III Section A, Lines 2 and 3 - Bad Debt Expense | IN CALCULATING BAD DEBT EXPENSE, DFCI USES A COMBINATION OF ACTUAL BAD DEBT WRITE OFFS AND HISTORICAL BAD DEBT FACTORS IN DETERMINING WHICH CURRENT ACCOUNTS RECEIVABLE ARE NOT LIKELY TO BE COLLECTED. IN FY21, DFCI INCLUDED AN ADDITIONAL RESERVE FOR SOME INTERNATIONAL ACCOUNTS THAT WERE DEEMED NOT LIKELY TO BE COLLECTED. ADDITIONALLY, DFCI DETERMINES THE AMOUNT OF BAD DEBT ATTRIBUTABLE TO INDIVIDUALS WHO ARE ELIGIBLE FOR FINANCIAL ASSISTANCE BASED ON A HISTORICAL ESTIMATE OF THE PERCENTAGE OF PATIENTS THAT HAVE QUALIFIED FOR FINANCIAL ASSISTANCE, WHICH IS APPLIED AGAINST TOTAL BAD DEBT. |
| Schedule H, Part V, Section B, Line 20d | DANA-FARBER DOES NOT ENGAGE IN PRESUMPTIVE ELIGIBILITY FOR ITS PATIENT FINANCIAL ASSISTANCE POLICY (FAP). THROUGH ITS PARTICIPATION IN THE MASSACHUSETTS HEALTH SAFETY NET, THE STATE SPONSORED UNCOMPENSATED PROGRAM, DANA-FARBER FIRST RELIES ON DEMONSTRATION OF INELIGIBILITY FOR MASSHEALTH PROGRAMS, SUCH AS HEALTH SAFETY NET, OR SIMILAR OUT OF STATE MEDICAID PROGRAMS, FROM PATIENTS APPLYING FOR ASSISTANCE. UPON DETERMINATION BY THE STATE AGENCY, DANA-FARBER WILL CONSIDER EACH CASE INDIVIDUALLY AND RELIES ON THE COMPLETION OF THE PATIENT FINANCIAL ASSISTANCE APPLICATION ("PFA APPLICATION") AND PROVISION OF NECESSARY SUPPORTING DOCUMENTATION. |
| Schedule H, Part V, Section B, Line 22 | DEPENDING ON A PATIENT'S FINANCIAL SITUATION, FAP-ELIGIBLE PATIENTS WERE CHARGED BETWEEN 0% TO 30% OF BILLED CHARGES, WHICH WAS NOT MORE THAN THE AGB. IN FY22, DFCI DETERMINED AGB ON AN ANNUAL BASIS USING THE "LOOK-BACK METHOD," DESCRIBED UNDER TREASURY REGULATION SECTION 1.501(R)-5(B)(1). SPECIFICALLY, DFCI'S ANNUAL AGB PERCENTAGE WAS EQUAL TO SUM OF ALL GROSS CHARGES DURING THE PRIOR FISCAL YEAR DIVIDED BY CLAIMS PAID IN CONNECTION WITH THOSE CHARGES. FOR PURPOSES OF THE AGB CALCULATION, CLAIMS PAID INCLUDED CLAIMS FOR EMERGENCY AND MEDICALLY NECESSARY CARE PAID BY BOTH MEDICARE FEE-FOR-SERVICE AND ALL PRIVATE HEALTH INSURERS AS PRIMARY PAYERS, TOGETHER WITH ANY ASSOCIATED PORTIONS OF THESE CLAIMS PAID BY MEDICARE BENEFICIARIES OR INSURED INDIVIDUALS IN THE FORM OF CO-PAYMENTS, CO-INSURANCE OR DEDUCTIBLES. |
| Schedule H, Part V, Section B, Line 16a FAP AVAILABLE WEBSITE | https://www.dana-farber.org/uploadedFiles/Pages/For_Patients_and_Families/Care_and_Treatment/Support_Services_and_Amenities/financial-assistance-full-policy.pdf |
| Schedule H, Part V, Section B, Line 16b FAP APPLICATION FORM WEBSITE | https://www.dana-farber.org/uploadedFiles/Pages/For_Patients_and_Families/Care_and_Treatment/Support_Services_and_Amenities/financial-assistance-full-policy.pdf |
| Schedule H, Part V, Section B, Line 16c PLAIN LANGUAGE FAP SUMMARY WEBSITE | https://www.dana-farber.org/uploadedFiles/Pages/For_Patients_and_Families/Care_and_Treatment/Support_Services_and_Amenities/financial-assistance-full-policy.pdf |
| Schedule H, Part I, Line 6a Community benefit report prepared by related organization | DFCI |
| Schedule H, Part III, Line 4 Bad debt expense - financial statement footnote | CONSISTENT WITH THE INSTITUTE'S MISSION, CARE IS PROVIDED TO PATIENTS REGARDLESS OF THEIR ABILITY TO PAY. THE INSTITUTE HAS DETERMINED IT HAS PROVIDED IMPLICIT PRICE CONCESSIONS TO UNINSURED PATIENTS AND PATIENTS WITH OTHER UNINSURED BALANCES (E.G. COPAYS AND DEDUCTIBLES). THE IMPLICIT PRICE CONCESSIONS INCLUDED IN ESTIMATING THE TRANSACTION PRICE REPRESENT THE DIFFERENCE BETWEEN AMOUNTS BILLED TO PATIENTS AND THE AMOUNTS THE INSTITUTE EXPECTS TO COLLECT BASED ON ITS COLLECTION HISTORY WITH THOSE PATIENTS. PATIENTS WHO MEET THE INSTITUTE'S CRITERIA FOR CHARITY CARE ARE PROVIDED CARE WITHOUT CHARGE OR AT AMOUNTS LESS THAN ESTABLISHED RATES. THE INSTIUTE HAS DETERMINED THAT IT HAS PROVIDED SUFFICIENT IMPLICIT PRICE CONCESSIONS FOR THESE ACCOUNTS. PRICE CONCESSIONS, INCLUDING CHARITY CARE, ARE NOT REPORTED AS REVENUE. |
| Schedule H, Part III, Line 8 Community benefit methodology for determining medicare costs | THE MEDICARE COST ON LINE 6 COMES FROM THE MEDICARE COST REPORT AND IS BASED ON MEDICARE'S COST FINDING PRINCIPLES AND METHODOLOGIES. WE STRONGLY BELIEVE THAT THE ENTIRE AMOUNT OF THE SHORTFALL OF $47,684,630 SHOULD BE TREATED AS A COMMUNITY BENEFIT AS THIS REPRESENTS THE INSTITUTE'S COMMITMENT TO THE ELDERLY AND DISABLED COMMUNITY BY PROVIDING SERVICES THAT ARE NOT REIMBURSED. |
| Schedule H, Part III, Line 9b Collection practices for patients eligible for financial assistance | WITHIN DFCI'S CREDIT AND COLLECTIONS POLICY THERE ARE PROVISIONS THAT DESCRIBE COLLECTION PRACTICES TO BE FOLLOWED FOR PATIENTS WHO ARE KNOWN TO QUALIFY FOR CHARITY CARE OR FINANCIAL ASSISTANCE IN ACCORDANCE WITH FEDERAL AND MASSACHUSETTS LAW. |
| Schedule H, Part V, Section B, Line 16a FAP website | - DANA-FARBER CANCER INSTITUTE, INC.: Line 16a URL: SEE PART VI - SUPPLEMENTAL INFORMATION; |
| Schedule H, Part V, Section B, Line 16b FAP Application website | - DANA-FARBER CANCER INSTITUTE, INC.: Line 16b URL: SEE PART VI - SUPPLEMENTAL INFORMATION; |
| Schedule H, Part V, Section B, Line 16c FAP plain language summary website | - DANA-FARBER CANCER INSTITUTE, INC.: Line 16c URL: SEE PART VI - SUPPLEMENTAL INFORMATION; |
| Schedule H, Part VI, Line 2 Needs assessment | DANA-FARBER CANCER INSTITUTE CONTINUOUSLY ASSESSES THE COMMUNITY NEEDS THROUGH OUR PARTICIPATION IN COMMUNITY COALITIONS, TASK FORCES, WORKING GROUPS AND DIRECT COMMUNICATION WITH THE COMMUNITY RESIDENTS THAT SERVE ON OUR EXTERNAL ADVISORY COMMITTEE AND ON OUR PATIENT AND FAMILY ADVISORY BOARD. A FULL DESCRIPTION OF OUR COMMUNITY ENGAGEMENT PROCESS CAN BE FOUND ON OUR WEBSITE BOTH IN THE COMMUNITY HEALTH NEEDS ASSESSMENT REPORT AND IN THE COMMUNITY HEALTH IMPLEMENTATION PLAN. |
| Schedule H, Part VI, Line 3 Patient education of eligibility for assistance | DFCI IS COMMITTED TO OFFERING FINANCIAL ASSISTANCE TO ELIGIBLE PATIENTS WHO DO NOT HAVE THE ABILITY TO PAY FOR THEIR MEDICAL SERVICES IN WHOLE OR IN PART. IN ORDER TO ACCOMPLISH THIS CHARITABLE GOAL, DFCI WIDELY PUBLICIZES ITS PATIENT FINANCIAL ASSISTANCE (PFA) POLICY WITHIN ITS FACILITIES, IN DIRECT COMMUNICATIONS WITH PATIENTS AND IN THE COMMUNITIES THAT IT SERVICES, PARTICULARLY IN THE COMMUNITIES WITH THE GREATEST UNMET HEALTH NEEDS. THE PFA POLICY, A PLAIN LANGUAGE PFA SUMMARY AND THE PFA APPLICATION ARE POSTED ON DFCI'S WEBSITE IN ENGLISH AND SPANISH. IN ADDITION, INFORMATION ABOUT THE PFA IS PROVIDED TO ALL PATIENTS AT REGISTRATION AND/OR ADMISSION, AND IS AVAILABLE UPON REQUEST, WITHOUT CHARGE, THROUGH A DFCI FINANCIAL COUNSELOR, CUSTOMER SERVICE REPRESENTATIVE, OR BY MAIL. FOLLOWING CARE, ALL BILLING STATEMENTS SENT TO A PATIENT INDICATE HOW THE PATIENT CAN OBTAIN INFORMATION ABOUT THE PFA POLICY. IN COLLABORATION WITH DFCI'S COMMUNITY PARTNERS, INFORMATION ABOUT THE FAP IS SHARED WITH RESIDENTS OF DFCI'S PRIORITY NEIGHBORHOODS. EFFORTS TO NOTIFY COMMUNITY MEMBERS MOST LIKELY TO REQUIRE ASSISTANCE INCLUDE DISTRIBUTING PLAIN LANGUAGE SUMMARIES OF THIS POLICY TO LOCAL COMMUNITY HEALTH CENTERS AND OTHER NON-PROFIT ORGANIZATIONS. |
| Schedule H, Part VI, Line 4 Community information | DANA-FARBER SERVES THE COMMUNITY OF EASTERN MASSACHUSETTS AND NEW ENGLAND, INCLUDING THE COMMUNITIES SURROUNDING ITS PRIMARY LOCATION IN BOSTON AND ITS SATELLITE LOCATIONS IN MILFORD, MASSACHUSETTS, WEYMOUTH, MASSACHUSETTS, BRIGHTON, MASSACHUSETTS, NEWTON, MASSACHUSETTS, METHUEN, MASSACHUSETTS AND LONDONDERRY, NEW HAMPSHIRE. DANA-FARBER'S COMMUNITY INCLUDES ADULTS AND CHILDREN WITH CANCER OR AT RISK OF DEVELOPING CANCER, AND THEIR FAMILIES. DANA-FARBER FOCUSES ITS COMMUNITY OUTREACH EFFORTS ON ITS PRIORITY BOSTON NEIGHBORHOODS OF ROXBURY, MISSION HILL, DORCHESTER, MATTAPAN AND JAMAICA PLAIN (WHICH COLLECTIVELY COMPRISE 39% OF BOSTON'S OVERALL POPULATION). TWO OF BOSTON'S MOST POPULATED NEIGHBORHOODS ARE DANA-FARBER PRIORITY NEIGHBORHOODS-DORCHESTER WITH 122,598 RESIDENTS, FOLLOWED BY ROXBURY WITH 49,028. WHITE RESIDENTS NOW MAKE UP LESS THAN HALF OF THE CITY'S RACIAL AND ETHNIC COMPOSITION (46%). BLACK OR AFRICAN AMERICAN RESIDENTS WERE THE SECOND LARGEST RACIAL AND ETHNIC GROUP (23%), FOLLOWED BY HISPANICS (18%) AND ASIANS (9%). THERE IS SUBSTANTIAL VARIATION IN THE RACIAL AND ETHNIC DIVERSITY BY DFCI PRIORITY NEIGHBORHOOD, WITH NEARLY THREE-QUARTERS OF MATTAPAN RESIDENTS AND HALF OF ROXBURY RESIDENTS IDENTIFYING AS BLACK OR AFRICAN AMERICAN. AMONG DANA-FARBER'S PRIORITY NEIGHBORHOODS, ROXBURY AND JAMAICA PLAIN HAVE THE LARGEST HISPANIC POPULATIONS WITH 29% AND 24% RESPECTIVELY, WHILE MISSION HILL AND DORCHESTER HAVE THE LARGEST ASIAN POPULATIONS AMONG THE PRIORITY NEIGHBORHOODS WITH 14% AND 10% RESPECTIVELY. THE MEDIAN INCOMES OF DANA-FARBER'S PRIORITY COMMUNITIES ARE GENERALLY MUCH LOWER THAN BOSTON OVERALL, WITH ROXBURY AT A MEDIAN INCOME OF $25,254, MISSION HILL AT $35,020, AND MATTAPAN AT $42,206. MANY OF DANA-FARBER'S PRIORITY NEIGHBORHOODS, ROXBURY AND MATTAPAN, ARE MORE LIKELY TO HAVE A GREATER POPULATION AT THE LOWER END OF THE INCOME SPECTRUM. RESIDENTS IN DANA-FARBER'S PRIORITY NEIGHBORHOODS APPEAR TO EXPERIENCE HIGHER RATES OF POVERTY THAN BOSTON OVERALL. FEMALE HEADED HOUSEHOLDS ARE ESPECIALLY VULNERABLE, WITH 45% OF ROXBURY FEMALE-HEADED HOUSEHOLDS LIVING BELOW THE POVERTY LINE. DESPITE ITS STATEWIDE REACH AND SERVICES PROVIDED THROUGH OUR SATELLITE OPERATIONS IN WEYMOUTH, ALLSTON/BRIGHTON, AND MILFORD, DANA-FARBER'S PRIORITIZATION OF THESE FIVE NEIGHBORHOODS WITHIN ITS LOCAL SERVICE AREA REFLECTS A COMMITMENT TO REDUCING DISPARITIES IN CANCER CARE AND IMPROVING THE HEALTH AND WELL-BEING OF NEIGHBORHOOD RESIDENTS. THROUGH OUR COLLABORATIVE APPROACH, THE SATELLITE LOCATIONS HAVE AGREED TO LEVERAGE EACH OTHER'S CANCER CONTROL EXPERTISE TO EXPAND AND STRENGTHEN OUR PROGRAMS SUCH AS BRINGING CANCER PREVENTION EFFORTS IN SPANISH TO THE ALLSTON/BRIGHTON AREA. |
| Schedule H, Part VI, Line 5 Promotion of community health | DANA-FARBER'S 2022-2025 COMMUNITY HEALTH NEEDS ASSESSMENT AND IMPLEMENTATION PLAN PROVIDE A ROBUST DESCRIPTION OF OUR COMPREHENSIVE CANCER CONTROL PROGRAMS AND SERVICES. THE REPORT ALSO PROVIDES A SUMMARY OF ACCOMPLISHMENTS FROM OUR LAST NEEDS ASSESSMENT AND SETS FORTH OUR COMMITMENT TO ADDRESSING THE NEW OPPORTUNITIES TO REDUCE THE CANCER BURDEN IN MEDICALLY UNDERSERVED COMMUNITIES IN BOSTON. THE REPORTS CAN BE FOUND USING THE FOLLOWING LINKS: COMMUNITY HEALTH NEEDS ASSESSMENT - HTTPS://WWW.DANA-FARBER.ORG/UPLOADEDFILES/PAGES/ABOUT_US/COMMUNITY_OUTREACH/CANCER-CHNA-REPORT-2022.PDF IMPLEMENTATION PLAN - HTTPS://WWW.DANA-FARBER.ORG/UPLOADEDFILES/PAGES/ABOUT_US/COMMUNITY_OUTREACH/COMMUNITY-HEALTH-IMPLEMENTATION-PLAN-2022-25.PDF IN ADDITION, DFCI FURTHERS ITS EXEMPT PURPOSE BY PROMOTING THE HEALTH OF THE COMMUNITY THROUGH DEVOTING THE VAST MAJORITY OF ITS SURPLUS FUNDS TO INSTITUTIONAL SUPPORTED RESEARCH (140 MILLION), BY PROVIDING FINANCIAL ASSISTANCE TO PATIENTS UNABLE TO AFFORD CARE AND BY MAINTAINING A COMMUNITY BOARD. |
| Schedule H, Part VI, Line 7 State filing of community benefit report | MA |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (30 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| AMERICAN CANCER SOCIETY | |||||||
| 250 Williams St | Atlanta | GA | 30303 | 131788491 | 501(c)(3) | $15,000 | Cancer Research and Development |
| FRIENDS OF DANA FARBER | |||||||
| 450 Brookline Ave | Boston | MA | 02215 | 371613621 | 501(c)(3) | $50,000 | Cancer Research and Development |
| CITY OF BOSTON | |||||||
| City Hall Plaza | Boston | MA | 02114 | 046001380 | 115 | $1,571,964 | Community Support |
| BOSTON PRIVATE INDUSTRY COUNCIL | |||||||
| 2 Oliver St | Boston | MA | 02109 | 042676661 | 501(c)(3) | $10,000 | Cancer Research and Development |
| CANCER RESEARCH INSTITUTE | |||||||
| 29 Broadway 4th Floor | New York | NY | 10006 | 131837442 | 501(c)(3) | $10,000 | Cancer Research and Development |
| COMMUNITY SERVINGS | |||||||
| 179 Amory Street | Jamaica Plain | MA | 02130 | 223154028 | 501(c)(3) | $15,000 | Community Support |
| ELLIE FUND INC | |||||||
| 200 Reservoir Street | Needham | MA | 02494 | 043280390 | 501(c)(3) | $10,000 | Cancer Research and Development |
| Harvard University | |||||||
| 60 Oxford St | Cambridge | MA | 02138 | 042103580 | 501(c)(3) | $1,366,895 | CANCER RESEARCH AND DEVLP |
| MADISON PARK DEVELOPMENT CORPORATION | |||||||
| 184 Dudley St | Roxbury | MA | 02119 | 237164223 | 501(c)(3) | $21,500 | Community Support |
| PROSTATE HEALTH EDUCATION NETWORK INC | |||||||
| 500 Victory Rd 4Th Fl | Quincy | MA | 02453 | 331042404 | 501(c)(3) | $30,000 | Cancer Research and Development |
| SWIM ACROSS AMERICA INC | |||||||
| 8508 Park Road No 389 | Charlotte | NC | 28210 | 223248256 | 501(c)(3) | $25,000 | Cancer Research and Development |
| LYNN COMMUNITY HEALTH CENTER | |||||||
| 269 Union Street | Lynn | MA | 01901 | 800538261 | 501(c)(3) | $7,500 | Community Support |
| WHITTIER STREET HEALTH CENTER | |||||||
| 1125 Tremont Street | Roxbury | MA | 02120 | 042619517 | 501(c)(3) | $49,818 | Community Support |
| MASSACHUSETTS LEAGUE OF COMMUNITY HEALTH CENTERS INC | |||||||
| 40 Court Street 10Th Floor | Boston | MA | 02108 | 042507409 | 501(c)(3) | $10,000 | Community Support |
| THE BREAST CANCER RESEARCH FOUNDATION | |||||||
| 60 EAST 56TH STREET 8TH FLOOR | NEW YORK | NY | 10022 | 133727250 | 501(c)(3) | $15,000 | Cancer Research and Development |
| THE COLORECTAL CANCER ALLIANCE | |||||||
| 1025 Vermont Avenue Nw Suite 1066 | Washington | DC | 20005 | 860947831 | 501(c)(3) | $20,000 | Cancer Research and Development |
| RIAN IMMIGRANT CENTER INC | |||||||
| One State Street 8Th Floor | Boston | MA | 02109 | 043063382 | 501(c)(3) | $6,000 | Community Support |
| SUSAN G KOMEN NEW ENGLAND | |||||||
| 5005 LBJ FREEWAY Suite 370 | Dallas | TX | 75380 | 751835298 | 501(c)(3) | $20,000 | Cancer Research and Development |
| Alternatives for Community and Environment with MPHA | |||||||
| 2201 Washington Street Suite 302 | Roxbury | MA | 02119 | 043228509 | 501(c)(3) | $199,996 | Community Support |
| Family Aid Boston | |||||||
| 3815 Washington St | Boston | MA | 01230 | 042105756 | 501(c)(3) | $200,000 | Community Support |
| Green Roots | |||||||
| 90 Everett Ave 3rd fl suite 10 | Chelsea | MA | 02150 | 812718273 | 501(c)(3) | $200,000 | Community Support |
| Project Bread | |||||||
| 145 Border Street | East Boston | MA | 02128 | 042931195 | 501(c)(3) | $99,946 | Community Support |
| Brookview House Inc | |||||||
| 2 Brookview Street | Dorchester | MA | 02124 | 223032466 | 501(c)(3) | $50,000 | Community Support |
| Enhance Asian Community on Health | |||||||
| 1 Franklin Street Unit 1207 | Boston | MA | 02110 | 472130807 | 501(c)(3) | $50,000 | Community Support |
| Sociedad Latina Inc | |||||||
| 1530 Tremont St | Roxbury | MA | 02120 | 042678255 | 501(c)(3) | $50,000 | Community Support |
| Allston Brighton Community Development Corporation | |||||||
| 18R Shepard Street Suite 100 | BOSTON | MA | 02135 | 042716278 | 501(c)(3) | $50,000 | Community Support |
| Inquilinos Boricuas En Accion Inc | |||||||
| 405 Shawmut Ave | Boston | MA | 02115 | 237090081 | 501(c)(3) | $50,000 | Community Support |
| Southern Jamaica Plain Health Center (BWH) | |||||||
| 640 Centre Street | Jamaica Plain | MA | 02130 | 042312909 | 501(c)(3) | $49,568 | Community Support |
| Team Maureen Inc | |||||||
| PO Box 422 | N Falmouth | MA | 02556 | 452473500 | 501(c)(3) | $21,930 | Community Support |
| Charles River Community Health Inc | |||||||
| 495 Western Avenue | Brighton | MA | 02135 | 237221597 | 501(c)(3) | $49,129 | Community Support |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 29 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)
| Grant TypeGrantTypeTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Valuation Method UsedValuationMethodUsedDesc | Non Cash AssistanceNonCashAssistanceDesc |
|---|---|---|---|---|---|
| Patient Assistance | 798 | $841,482 | |||
| Patient Assistance | 3295 | $1,705,862 | FMV | Asst Living Travel |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds. | FormAndLineReferenceDesc |
| Explanation | PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS ALL GRANTS AND DONATIONS TO DOMESTIC ORGANIZATIONS WERE GIVEN TO 501(C)(3) ORGANIZATIONS TO FULFILL THEIR MISSIONS, OR GOVERNMENT ENTITIES. ALL GRANT FUNDS TO INDIVIDUALS WERE PROVIDED BASED ON EITHER (AND ONLY) 1) MEANS-TESTED FINANCIAL NEED, OR 2) CLINICALLY-DETERMINED IMPROVEMENT TO QUALITY-OF-LIFE. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (24 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laurie H Glimcher MD | ||||||||||||||
| TRUSTEE, PRESIDENT, AND CEO | $1,280,223 | $0 | $212,479 | $0 | $2,179,953 | $0 | $304,525 | $0 | $16,878 | $0 | $3,994,058 | $0 | $1,191,078 | $0 |
| Richard S Boskey ESQ | ||||||||||||||
| Former Officer | $610,413 | $0 | $148,600 | $0 | $40,387 | $0 | $33,925 | $0 | $17,423 | $0 | $850,748 | $0 | $0 | $0 |
| Bruce Johnson MD | ||||||||||||||
| Senior Advisor to President CEO | $562,385 | $0 | $61,447 | $0 | $47,309 | $0 | $33,113 | $0 | $23,471 | $0 | $727,725 | $0 | $0 | $0 |
| James Terwilliger | ||||||||||||||
| Former Officer | $0 | $0 | $0 | $0 | $360,500 | $0 | $0 | $0 | $0 | $0 | $360,500 | $0 | $0 | $0 |
| William Hahn MD PHD | ||||||||||||||
| COO EVP | $738,744 | $0 | $64,280 | $0 | $52,112 | $0 | $33,925 | $0 | $3,477 | $0 | $892,538 | $0 | $0 | $0 |
| Michael L Reney | ||||||||||||||
| CFO Assistant Treasurer | $723,987 | $0 | $60,983 | $0 | $50,499 | $0 | $33,925 | $0 | $3,556 | $0 | $872,950 | $0 | $0 | $0 |
| John Ryan ESQ | ||||||||||||||
| Asst. Sec. Gen. Cnsl. (End 1/14/22) | $606,869 | $0 | $0 | $0 | $10,875 | $0 | $0 | $0 | $31,945 | $0 | $649,689 | $0 | $0 | $0 |
| James D Griffin MD | ||||||||||||||
| Professor of Medicine | $629,891 | $0 | $1,000 | $0 | $50,528 | $0 | $33,925 | $0 | $25,715 | $0 | $741,059 | $0 | $0 | $0 |
| Elizabeth Liebow | ||||||||||||||
| Chief Integration Officer | $406,272 | $0 | $34,600 | $0 | $17,790 | $0 | $33,925 | $0 | $20,749 | $0 | $513,336 | $0 | $0 | $0 |
| Drew Memmott | ||||||||||||||
| Former Key Employee | $244,456 | $0 | $34,460 | $0 | $22,903 | $0 | $23,670 | $0 | $15,396 | $0 | $340,885 | $0 | $0 | $0 |
| Sylvia A Bartel RPh MHP | ||||||||||||||
| VP of Pharmacy Services | $304,329 | $0 | $14,321 | $0 | $3,340 | $0 | $33,925 | $0 | $31,824 | $0 | $387,739 | $0 | $0 | $0 |
| Craig A Bunnell MD | ||||||||||||||
| Chief Medical Officer | $655,199 | $0 | $62,581 | $0 | $44,253 | $0 | $33,925 | $0 | $6,643 | $0 | $802,601 | $0 | $0 | $0 |
| Melany Duval | ||||||||||||||
| SVP of Development | $633,289 | $0 | $53,457 | $0 | $38,737 | $0 | $33,925 | $0 | $17,845 | $0 | $777,253 | $0 | $0 | $0 |
| Benjamin Ebert MD PhD | ||||||||||||||
| Chair of Medical Oncology | $91,676 | $0 | $1,000 | $0 | $106,853 | $0 | $7,801 | $0 | $1,068 | $0 | $208,398 | $0 | $0 | $0 |
| Wendy Gettleman | ||||||||||||||
| VP of Facilities Management Real Estate | $329,991 | $0 | $15,444 | $0 | $2,364 | $0 | $33,650 | $0 | $35,638 | $0 | $417,087 | $0 | $0 | $0 |
| Kevin Haigis | ||||||||||||||
| Chief Scientific Officer | $480,711 | $0 | $41,655 | $0 | $2,473 | $0 | $54,253 | $0 | $4,227 | $0 | $583,319 | $0 | $0 | $0 |
| Maria Megdal | ||||||||||||||
| SVP of Institue Operations | $459,568 | $0 | $38,925 | $0 | $20,425 | $0 | $33,925 | $0 | $18,604 | $0 | $571,447 | $0 | $0 | $0 |
| Jeffrey Meyerhardt MD PhD | ||||||||||||||
| Chief Clinical Research Officer | $444,194 | $0 | $24,650 | $0 | $19,723 | $0 | $33,925 | $0 | $36,937 | $0 | $559,429 | $0 | $0 | $0 |
| Barrett J Rollins MD PHD | ||||||||||||||
| Sr. Advisor President CEO | $481,386 | $0 | $1,000 | $0 | $30,640 | $0 | $33,925 | $0 | $17,516 | $0 | $564,467 | $0 | $0 | $0 |
| Edward J Benz JR MD | ||||||||||||||
| President CEO Emeritus | $376,204 | $0 | $1,000 | $0 | $1,786,450 | $0 | $33,925 | $0 | $17,560 | $0 | $2,215,139 | $0 | $818,568 | $0 |
| Michael Constantine MD | ||||||||||||||
| Milford Medical Dir. - Hematol Onc. | $658,423 | $0 | $53,214 | $0 | $47,104 | $0 | $21,842 | $0 | $36,279 | $0 | $816,862 | $0 | $0 | $0 |
| Matthew Meyerson MD | ||||||||||||||
| Professor | $497,614 | $0 | $1,000 | $0 | $404,933 | $0 | $33,925 | $0 | $35,951 | $0 | $973,423 | $0 | $0 | $0 |
| Robert Soiffer MD | ||||||||||||||
| Chief of Hemotologic Malignancies | $585,173 | $0 | $85,736 | $0 | $41,887 | $0 | $33,925 | $0 | $20,252 | $0 | $766,973 | $0 | $0 | $0 |
| Eric Winer MD | ||||||||||||||
| Chief of Div. of Women's Cancers | $601,424 | $0 | $109,055 | $0 | $87,060 | $0 | $33,925 | $0 | $13,670 | $0 | $845,134 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule J, Part I, Line 4a Severance or change-of-control payment | JAMES TERWILLIGER RECEIVED SEVERANCE PAYMENTS IN THE AMOUNT OF $360,500. THIS AMOUNT IS INCLUDED ON SCHEDULE J, PART II, COLUMN B (III). |
| Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan | THE FOLLOWING INDIVIDUALS PARTICIPATE IN 457(F) PLANS ESTABLISHED BY DFCI; TAXABLE AMOUNTS ARE INCLUDED IN REPORTABLE COMPENSATION IN SCHEDULE J, PART II, COLUMN (B)(III): GLIMCHER, LAURIE, MD - $2,162,958 BENZ, EDWARD J. JR., MD - $1,779,950 HAHN, WILLIAM, MD, PHD - $47,210 RENEY, MICHAEL - $45,597 CONSTANTINE, MICHAEL, MD - $39,616 BUNNELL, CRAIG A. MD - $38,661 GRIFFIN, JAMES D., MD - $36,403 DUVAL, MELANY - $36,242 WINER, ERIC, MD - $33,172 SOIFFER, ROBERT, MD - $31,461 JOHNSON, BRUCE MD - $29,099 BOSKEY, RICHARD S., ESQ - $28,155 MEYERSON, MATTHEW - $22,783 MEMMOTT, DREW - $21,217 ROLLINS, BARRETT J., MD, PHD - $20,340 MEGDAL, MARIA - $18,178 LIEBOW, ELIZABETH - $12,802 |
| Schedule J, Part I, Line 7 Non-fixed payments | DURING THE YEAR, THE CEO, COO, CFO, GENERAL COUNSEL, CERTAIN KEY EMPLOYEES AND HIGHEST COMPENSATED EMPLOYEES WERE ELIGIBLE TO RECEIVE AN INCENTIVE PAYMENT, A PORTION OF WHICH HAS A NON-FIXED PAYMENT PAYABLE AT THE DISCRETION OF THE CEO AND IN THE CASE OF THE CEO, THE BOARD OF TRUSTEES, IF THE ORGANIZATION MEETS CERTAIN PERFORMANCE GOALS. THE MAXIMUM NON-FIXED PORTION OF THESE INCENTIVE PAYMENTS IS BETWEEN 8% (CEO - 40% MAX, OF THAT 32% TEAM, 8% INDIVIDUAL) AND 4% (SVP - 20% MAX, OF THAT 16% TEAM AND 4% INDIVIDUAL; VP - 10% MAX, OF THAT 6% TEAM AND 4% INDIVIDUAL; AND (EVP-30% MAX, OF THAT 24% TEAM AND 6% INDIVIDUAL). OTHER REPORTABLE COMPENSATION INCLUDES LOAN FORGIVENESS AND CURRENT YEAR VESTING AMOUNTS IN DANA-FARBER INSTITUTE'S SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (4 entries)
| Bond ReferenceBondReferenceCd | Bond Issuer EINBondIssuerEIN | Bond IssuedBondIssuedDt | Issue PriceIssuePriceAmt | PurposePurposeDesc | DefeasedDefeasedInd | On Behalf Of IssuerOnBehalfOfIssuerInd | Pool FinancingPoolFinancingInd | CUSIPCUSIPNum |
|---|---|---|---|---|---|---|---|---|
| MASSACHUSETTS DEVELOPMENT FINANCE AGENCY | ||||||||
| A | 043431814 | 2015-08-03 | $92,500,000 | THE BOND ISSUE WAS USED TO REFUND SERIES L-1 BONDS ISSUED ON 5/22/2008. | false | false | false | |
| MASSACHUSETTS DEVELOPMENT FINANCE AGENCY | ||||||||
| B | 043431814 | 2016-06-23 | $281,786,480 | (SEE STATEMENT) | false | false | false | 05758XNZ0 |
| MASSACHUSETTS DEVELOPMENT FINANCE AGENCY | ||||||||
| C | 043431814 | 2019-09-03 | $60,255,238 | THE BOND ISSUE WAS USED TO REFUND SERIES K BONDS ISSUED ON 5/22/2008. | false | false | false | 57584YVC0 |
| MASSACHUSETTS DEVELOPMENT FINANCE AGENCY | ||||||||
| D | 043431814 | 2021-07-28 | $57,500,000 | THE BOND ISSUE WAS USED TO REFUND SERIES L-2A BONDS ISSUED ON 7/2/2012. | false | false | false | |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (4 entries)
| Bond ReferenceBondReferenceCd | Total ProceedsTotalProceedsAmt | Other Spent ProceedsOtherSpentProceedsAmt | Substantial CompletionSubstantialCompletionYr | Refunding Tax Exempt BondsRefundingTaxExemptBondsInd | Refunding Taxable BondsRefundingTaxableBondsInd | Final Allocation MadeFinalAllocationMadeInd | Adequate Books And Rec MaintAdequateBooksAndRecMaintInd | Capitalized InterestCapitalizedInterestAmt | Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt | Capital ExpendituresCapitalExpendituresAmt |
|---|---|---|---|---|---|---|---|---|---|---|
| A | $92,500,000 | $92,500,000 | 2015 | Yes (true) | false | Yes (true) | Yes (true) | |||
| B | $282,864,401 | 2019 | false | false | Yes (true) | Yes (true) | $1,077,921 | $2,486,701 | $279,299,779 | |
| C | $60,255,238 | $59,091,281 | 2019 | Yes (true) | false | Yes (true) | Yes (true) | $1,163,957 | ||
| D | $57,500,000 | $57,500,000 | 2021 | Yes (true) | false | Yes (true) | Yes (true) |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (4 entries)
| Bond ReferenceBondReferenceCd | Owning Bond Financed PropertyOwningBondFinancedPropertyInd | Any Lease ArrangementsAnyLeaseArrangementsInd | Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd | Engage Bond Counsel ContractsEngageBondCounselContractsInd | Any Research AgreementsAnyResearchAgreementsInd | Engage Bond Counsel ResearchEngageBondCounselResearchInd | Total Private Business UseTotalPrivateBusinessUsePct | Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd | Change In Use Bond Financed PropChangeInUseBondFinancedPropInd | Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd |
|---|---|---|---|---|---|---|---|---|---|---|
| A | false | false | Yes (true) | Yes (true) | Yes (true) | Yes (true) | 0.0 | false | false | Yes (true) |
| B | false | false | false | Yes (true) | Yes (true) | 0.0 | false | false | Yes (true) | |
| C | false | false | Yes (true) | Yes (true) | Yes (true) | Yes (true) | 0.0 | false | false | Yes (true) |
| D | false | false | Yes (true) | Yes (true) | Yes (true) | Yes (true) | 0.0 | false | false | Yes (true) |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (4 entries)
| Bond ReferenceBondReferenceCd | Form8038 T FiledForm8038TFiledInd | Rebate Not Due YetRebateNotDueYetInd | Exception To RebateExceptionToRebateInd | No Rebate DueNoRebateDueInd | Variable Rate IssueVariableRateIssueInd | Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd | Term Of HedgeTermOfHedgePct | Superintegrated HedgeSuperintegratedHedgeInd | Hedge TerminatedHedgeTerminatedInd | Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd | Gross Proceeds InvestedGrossProceedsInvestedInd | Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY CAPITAL SERVICES INC | ||||||||||||
| A | false | false | false | Yes (true) | Yes (true) | Yes (true) | 39.8 | false | false | false | false | Yes (true) |
| (no name) | ||||||||||||
| B | false | false | false | Yes (true) | false | false | false | false | Yes (true) | |||
| (no name) | ||||||||||||
| C | false | false | false | Yes (true) | false | false | false | false | Yes (true) | |||
| MORGAN STANLEY CAPITAL SERVICES INC | ||||||||||||
| D | false | false | Yes (true) | false | Yes (true) | Yes (true) | 39.8 | false | false | false | false | Yes (true) |
Procedures Corrective Action ProceduresCorrectiveActionGrp (4 entries)
| Bond ReferenceBondReferenceCd | Procedures Corrective ActionProceduresCorrectiveActionInd |
|---|---|
| A | Yes (true) |
| B | Yes (true) |
| C | Yes (true) |
| D | Yes (true) |
Supplemental Information Detail SupplementalInformationDetail (6 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule K, Part I, Column (f) B (F) DESCRIPTION OF PURPOSE | THE BOND ISSUE WAS USED TO PARTIALLY COVER THE ACQUISITION AND FIT-OUT OF RESEARCH SPACE AND VIVARIUM AT THE LONGWOOD CENTER; TO PARTIALLY COVER THE REPLACEMENT OF HVAC SYSTEM AT THE SMITH BUILDING; TO COVER THE RELOCATION TO, RECONSTRUCTION AND EQUIPPING OF THE INSTITUTE'S CELL MANIPULATION CORE FACILITY; AND TO COVER THE COSTS OF BOND ISSUANCE AND INTEREST DURING THE CONSTRUCTION PERIOD AS WELL AS OTHER CAPITAL PROJECTS. |
| Schedule K, Part IV SCHEDULE K, PART IV (ARBITRAGE) | D 2 (B) THIS ISSUANCE WAS REFUNDED IN 2021 AND HAD NO INVESTED ASSETS AND QUALIFIES FOR 6-MONTH SPENDING EXCEPTION. E 2 (B) THIS ISSUANCE WAS REFUNDED IN 2021 AND HAD NO INVESTED ASSETS AND QUALIFIES FOR 6-MONTH SPENDING EXCEPTION. |
| Schedule K, Part II (PROCEEDS) | B 3 THE TOTAL PROCEEDS OF $282,864,400 INCLUDE INVESTMENT EARNINGS IN THE AMOUNT OF $1,077,921. |
| Schedule K, Part IV, Line 2c COLUMN A | Issuer name: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY The calculation for computing no rebate due was performed on 11/01/2020 |
| Schedule K, Part IV, Line 2c COLUMN B | Issuer name: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY The calculation for computing no rebate due was performed on 11/01/2020 |
| Schedule K, Part IV, Line 2c COLUMN C | Issuer name: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY The calculation for computing no rebate due was performed on 11/01/2020 |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
Issuer Name IssuerName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MASSACHUSETTS DEVELOPMENT FINANCE AGENCY | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Issuer EIN | 043431814 | BondIssuerEIN |
| Bond Issued | 2021-07-28 | BondIssuedDt |
| Issue Price | $35,000,000 | IssuePriceAmt |
| Purpose | THE BOND ISSUE WAS USED TO REFUND SERIES L-2B BONDS ISSUED ON 7/2/2012. | PurposeDesc |
| Defeased | false | DefeasedInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Pool Financing | false | PoolFinancingInd |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Total Proceeds | $35,000,000 | TotalProceedsAmt |
| Other Spent Proceeds | $35,000,000 | OtherSpentProceedsAmt |
| Substantial Completion | 2021 | SubstantialCompletionYr |
| Refunding Tax Exempt Bonds | Yes (true) | RefundingTaxExemptBondsInd |
| Refunding Taxable Bonds | false | RefundingTaxableBondsInd |
| Final Allocation Made | Yes (true) | FinalAllocationMadeInd |
| Adequate Books And Rec Maint | Yes (true) | AdequateBooksAndRecMaintInd |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Owning Bond Financed Property | false | OwningBondFinancedPropertyInd |
| Any Lease Arrangements | false | AnyLeaseArrangementsInd |
| Mgmt Contract Bond Fincd Prop | Yes (true) | MgmtContractBondFincdPropInd |
| Engage Bond Counsel Contracts | Yes (true) | EngageBondCounselContractsInd |
| Any Research Agreements | Yes (true) | AnyResearchAgreementsInd |
| Engage Bond Counsel Research | Yes (true) | EngageBondCounselResearchInd |
| Total Private Business Use | 0.0 | TotalPrivateBusinessUsePct |
| Bond Iss Meet Prvt Sec Pymt Test | false | BondIssMeetPrvtSecPymtTestInd |
| Change In Use Bond Financed Prop | false | ChangeInUseBondFinancedPropInd |
| Procs Nonqualified Bond Remdtd | Yes (true) | ProcsNonqualifiedBondRemdtdInd |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Form8038 T Filed | false | Form8038TFiledInd |
| Rebate Not Due Yet | false | RebateNotDueYetInd |
| Exception To Rebate | Yes (true) | ExceptionToRebateInd |
| No Rebate Due | false | NoRebateDueInd |
| Variable Rate Issue | Yes (true) | VariableRateIssueInd |
| Hedge Identified In Bks And Rec | Yes (true) | HedgeIdentifiedInBksAndRecInd |
Hedge Provider Name HedgeProviderName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MORGAN STANLEY CAPITAL SERVICES INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Term Of Hedge | 39.8 | TermOfHedgePct |
| Superintegrated Hedge | false | SuperintegratedHedgeInd |
| Hedge Terminated | false | HedgeTerminatedInd |
| Gross Proceeds Invested In GIC | false | GrossProceedsInvestedInGICInd |
| Gross Proceeds Invested | false | GrossProceedsInvestedInd |
| Written Proc To Monitor Reqs | Yes (true) | WrittenProcToMonitorReqsInd |
Procedures Corrective Action ProceduresCorrectiveActionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Procedures Corrective Action | Yes (true) | ProceduresCorrectiveActionInd |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (4 entries)
| Relationship With OrgRelationshipWithOrgTxt | Loan PurposeLoanPurposeTxt | Loan From OrganizationLoanFromOrganizationInd | Original PrincipalOriginalPrincipalAmt | Balance DueBalanceDueAmt | DefaultDefaultInd | Board Or Committee ApprovalBoardOrCommitteeApprovalInd | Written AgreementWrittenAgreementInd |
|---|---|---|---|---|---|---|---|
| Melany Duval | |||||||
| Employee | Housing Loan | Yes (X) | $150,000 | $93,750 | false | Yes (true) | Yes (true) |
| Benjamin Ebert | |||||||
| Employee | Housing Loan | Yes (X) | $500,000 | $133,333 | false | Yes (true) | Yes (true) |
| Kevin Haigis | |||||||
| Employee | Housing Loan | Yes (X) | $100,000 | $75,833 | false | Yes (true) | Yes (true) |
| Elizabeth Liebow | |||||||
| Employee | Housing Loan | Yes (X) | $150,000 | $128,750 | false | Yes (true) | Yes (true) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $431,666 | TotalBalanceDueAmt |
Schedule M IRS990ScheduleM
Clothing And Household Goods ClothingAndHouseholdGoodsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Noncash Contributions Rpt F990 | $1,689,480 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | Other | MethodOfDeterminingRevenuesTxt |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 231 | ContributionCnt |
| Noncash Contributions Rpt F990 | $21,219,726 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | Other - Fair Market Value | MethodOfDeterminingRevenuesTxt |
Food Inventory FoodInventoryGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 24 | ContributionCnt |
| Noncash Contributions Rpt F990 | $173,806 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | Other - Letter from Donor | MethodOfDeterminingRevenuesTxt |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | Miscellaneous | Desc |
| Contribution | 6 | ContributionCnt |
| Noncash Contributions Rpt F990 | $235,815 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | Other - Letter from Donor | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule M, Part I COLUMN (B) | DANA-FARBER CANCER INSTITUTE, INC. IS REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED. |
| Schedule M, Part I, Line 33 Noncash contribution amounts not reported | DANA-FARBER CANCER INSTITUTE, INC. RECEIVED DONATIONS OF ART, BOOKS, AND OTHER GOODS THAT IT DISPLAYS IN ITS PROPERTIES. THESE GOODS HAVE VALUES THAT ARE EITHER NOMINAL OR ARE NOT READILY DETERMINABLE AND ARE, THEREFORE, NOT INCLUDED AS REVENUE. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (14 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part I, Line 1 | THE MISSION OF DANA-FARBER CANCER INSTITUTE, INC. (DFCI) IS TO PROVIDE EXPERT, COMPASSIONATE, AND EQUITABLE CARE TO CHILDREN, ADULTS, AND THEIR FAMILIES, WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. WE TRAIN NEW GENERATIONS OF CLINICIANS AND SCIENTISTS, DISSEMINATE INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES AROUND THE WORLD, AND REDUCE THE IMPACT OF CANCER, WHILE AT ALL TIMES MAINTAINING A FOCUS ON THOSE COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED. |
| Form 990, Part III, Line 1 | THE MISSION OF DANA-FARBER CANCER INSTITUTE, INC. (DFCI) IS TO PROVIDE EXPERT, COMPASSIONATE, AND EQUITABLE CARE TO CHILDREN, ADULTS, AND THEIR FAMILIES, WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. WE TRAIN NEW GENERATIONS OF CLINICIANS AND SCIENTISTS, DISSEMINATE INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES AROUND THE WORLD, AND REDUCE THE IMPACT OF CANCER, WHILE AT ALL TIMES MAINTAINING A FOCUS ON THOSE COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED. |
| Form 990, Part III, Line 4a | CLINICAL CARE As one of the leading cancer centers in the world, Dana-Farber Cancer Institute provides compassionate, comprehensive, and personalized care to adults and children with cancer, blood disorders, and related diseases. In fiscal year 2022, our expert clinicians and caregivers at our specialized treatment centers worked together to deliver the latest therapies to our patients through 1,288 inpatient admissions, 368,976 outpatient MD visits, and 201,477 infusion treatments. Since its founding in 1947 by Sidney Farber, MD, Dana-Farber has followed his vision for a cancer center that is just as dedicated to discoveries in cancer research as it is to delivering expert, compassionate care. Our Institute is a founding member of Dana-Farber/Harvard Cancer Center and one of 53 NCI-designated Comprehensive Cancer Centers in the U.S. We are the only hospital ranked in the top four nationally by U.S News and World Report in both adult and pediatric cancer care. In 2022, we offered more than 1,100 clinical trials. |
| Form 990, Part III, Line 4b | RESEARCH Scientific work at Dana-Farber is based on the premise that basic and clinical investigation are complementary and reinforcing activities. To encourage this cross-pollination of ideas, the Institute has developed an organizational framework that fosters collaborations among investigators from different disciplines. The result is an intense scientific impact on a group of diseases that continue to represent one of humanity's greatest health challenges. Some recent advances include: Novel "conjugate" therapy outperforms standard treatment for recurrent ovarian cancer: In an international clinical trial co-led by Dana-Farber investigators, a therapy made by fusing an antibody to a drug molecule produced substantially better results than standard therapy in patients with recurrent ovarian cancer resistant to platinum-based chemotherapy. Study finds Racial inequities in access to opioids among older patients with terminal cancer: Older Black and Hispanic patients with advanced cancer are less likely than White patients to receive pain-relieving opioid medicines in the last weeks of life, a study by Dana-Farber investigators found. Genetic variations increase risk of adverse side effects from cancer immunotherapy: Research by Dana-Farber scientists identified, for the first time, genetic alterations that place patients at high risk for complications from immune checkpoint inhibitor drugs. Study offers encouragement for younger women with breast cancer hoping to pursue pregnancy: A Dana-Farber-led study of patients with breast cancer who were 42 or younger found that those who paused endocrine therapy to try to become pregnant had similar short-term rates of breast cancer recurrence as women who did not pause treatment for pregnancy. Most participants who paused treatment went on to conceive and delivery healthy babies. Patients with cancer and a suppressed immune system at high risk for severe COVID if treated with systemic drug therapies: Patients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than those who haven't received such therapies in the three months before their COVID diagnosis, a study led by Dana-Farber investigators found. Digital platform quickly matches patients with cancer to clinical trials of targeted therapy: MatchMiner, a computer-based platform developed at Dana-Farber, makes it faster and easier to match patients to clinical trials of targeted therapies for their specific type of cancer. Three-drug combination slows progression of advanced kidney cancer: Adding a drug known as a targeted kinase inhibitor to a two-drug immunotherapy regimen showed the progression of advanced kidney cancer in previously untreated patients, research by Dana-Farber scientists found. Online tool identifies people likely to benefit from genetic testing for inherited cancer risk: An online tool - PREMMplus - developed at Dana-Farber can rapidly identify people who should be tested for inherited genetic changes that raise the risk of developing certain cancers, a study showed. Scientists identify a key gene activated in most cancer types: Scientists at Dana-Farber and the Broad Institute of MIT and Harvard discovered that the gene FOXR2, which is normally idle in most tissues, is activated in at least 70% of cancer types, making it a promising target for future therapies. Genomic profiling of pediatric tumors can enhance patients' care: By doing a molecular analysis of hundreds of tumors from children with cancer, Dana-Farber scientists found that the vast majority had clinically significant genetic alterations - information that can improve diagnosis and, potentially, treatment. Targeted drug achieves strong response rate in lung tumor with KRAS gene mutation: Nearly 43% of patients with non-small cell lung cancer harboring a specific mutation in the KRAS gene responded to the targeted agent adagrasib, which also showed activity against tumors that had spread from the lungs to the brain, a study led by Dana-Farber investigators found. Race and poverty linked to worse outcomes in children with high-risk neuroblastoma: Children with high-risk neuroblastoma had worse outcomes if they were from historically marginalized or lower-income populations or were on public rather than private insurance, investigators at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center found. |
| Form 990, Part III, Line 4c | COMMUNITY BENEFITS THE ROLE OF DANA-FARBER'S COMMUNITY BENEFITS OFFICE IS TO SUPPORT THE INSTITUTE'S GOAL TO REDUCE CANCER RISK AMONG MEDICALLY UNDERSERVED POPULATIONS. WE WORK WITH CITY AND STATE HEALTH DEPARTMENTS, COMMUNITY PARTNERS, AND BOSTON-BASED COALITIONS TO ASSESS AND MONITOR THE NEEDS OF LOCAL RESIDENTS WITH RESPECT TO CANCER CONTROL. IN COLLABORATION WITH STAFF THROUGHOUT DANA-FARBER, WE SERVE AS A BRIDGE WITH COMMUNITY ORGANIZATIONS AND ESTABLISH EVIDENCE-BASED AND SUSTAINABLE OUTREACH PROGRAMS. WE ARE ON THE FRONT LINES OF SUPPORTING AND COLLABORATING ON PROGRAMS DESIGNED TO ELIMINATE DISPARITIES IN BREAST, COLON, AND SKIN CANCER; EDUCATE DIVERSE POPULATIONS ABOUT TOBACCO CESSATION, HUMAN PAPILLOMAVIRUS (HPV) PREVENTION AND SCREENING; AND STRENGTHEN THE SUPPORT SYSTEM FOR MEDICALLY UNDERSERVED POPULATIONS. IN SHORT, WE ARE COMMITTED TO MAKING DANA-FARBER'S CARE AND RESEARCH FINDINGS MORE ACCESSIBLE TO EVERYONE WITHIN AND OUTSIDE ITS WALLS. IN FY 2022: A TOTAL OF 1,333 INDIVIDUALS WERE REACHED THROUGH 21 COMMUNITY EDUCATION, OUTREACH, AND SCREENING EVENTS. PROGRAM VOLUMES HAVE CONTINUED TO BE IMPACTED BY THE ONGOING COVID-19 PANDEMIC. THE COMMUNITY BENEFITS OFFICE HAS CONTINUED TO PIVOT TO ADAPT TO CHALLENGES RELATED TO THE ONGOING COVID-19 PANDEMIC. IN PARTICULAR, THE COMMUNITY BENEFITS OFFICE CONTINUES TO PROVIDE EDUCATION VIRTUALLY IN PARTNERSHIP WITH UNION CAPITAL BOSTON (UCB) AND OTHER COMMUNITY PARTNERS AND IS WORKING TO EXPAND AND STRENGTHEN DIGITAL EDUCATION AND OUTREACH STRATEGIES. FY22 PROGRAMMATIC HIGHLIGHTS ARE AS FOLLOWS: DANA-FARBER SUCCESSFULLY EXPANDED NEW COMMUNITY-FACING PATIENT NAVIGATION PROGRAM TO THE THORACIC CENTER, WITH PLANS TO EMBED THIS MODEL INTO ALL MAJOR CLINICAL AREAS AT DANA-FARBER. DANA-FARBER'S MAMMOGRAPHY SERVICES PROVIDED 1,914 MAMMOGRAMS ON THE VAN AND AT THE MAMMOGRAPHY SUITE AT WHITTIER STREET HEALTH CENTER IN ROXBURY. DANA-FARBER'S SUN SAFETY PROGRAM PROVIDED 16 IN-PERSON SUN SAFETY SCREENING EVENTS WITH ADDED HEALTH AND SAFETY MEASURES AND APPROVAL FROM LOCAL HEALTH DEPARTMENTS. 801 PARTICIPANTS WERE SCREENED BY A DERMATOLOGIST AND 182 PEOPLE WERE REFERRED FOR FOLLOW-UP APPOINTMENTS. 71 PARTICIPANTS WERE REFERRED FOR A BIOPSY. DANA-FARBER'S TOBACCO TREATMENT PROGRAM RECEIVED 67 REFERRALS AND PROVIDED 60 INDIVIDUAL TOBACCO CESSATION COUNSELING SESSIONS TO 20 PATIENTS. 19 PARTICIPANTS WERE ABLE TO REDUCE THEIR TOTAL NUMBER OF CIGARETTES SMOKED PER DAY, AND 7 OF THESE REPORTED BEING ABLE TO QUIT COMPLETELY. THE TOBACCO TREATMENT PROGRAM CONTINUED TO PROVIDE FINANCIAL INCENTIVES FOR PARTICIPANTS ENROLLED IN THE PROGRAM. STOP AND SHOP GIFT CARDS WERE PROVIDED AFTER EACH COUNSELING SESSION TO ENCOURAGE INDIVIDUALS TO REDUCE THEIR TOBACCO USAGE AND QUIT SMOKING. DANA-FARBER CONTINUED IT'S PARTNERSHIP WITH TEAM MAUREEN TO LEAD THE STATEWIDE MASSACHUSETTS HPV COALITION. THIS YEAR, THE COALITION'S ORAL HPV TASK FORCE CONTINUED TO PROVIDE HPV EDUCATION TO ORAL HEALTH PROVIDERS AND DISTRIBUTED THE SECOND EDITION OF THEIR DENTAL TOOLKIT FOR PROVIDERS AND PATIENTS IN 7 LANGUAGES. ADDITIONALLY, DANA-FARBER PLAYED A LEADING ROLE IN ORGANIZING THE ANNUAL HPV-RELATED CANCER SUMMIT, WHICH ENGAGED APPROXIMATELY 105 MEDICAL AND DENTAL PROVIDERS, PUBLIC HEALTH PROFESSIONALS AND COMMUNITY ADVOCATES ON THE LATEST HPV RESEARCH AND BEST PRACTICES. DANA-FARBER PROVIDED SINGLE-YEAR DETERMINATION OF NEED COMMUNITY-CLINICAL LINKAGES FUNDING TO EIGHT NON-PROFIT ORGANIZATIONS IN GREATER BOSTON TO IMPROVE LINKAGES TO HEALTH AND SUPPORT SERVICES. DANA-FARBER LAUNCHED AND EVALUATED THE FIRST YEAR OF DANA-FARBER'S MULTI-YEAR SYSTEMS LEVEL FUNDING, WHICH WAS AWARDED TO FOUR NON-PROFIT ORGANIZATIONS IN GREATER BOSTON TO ADDRESS ENVIRONMENTAL JUSTICE, FOOD INSECURITY, AND CHILD HOMELESSNESS. DANA-FARBER COMMITTED $500K TO THE HEALTHY RETAIL COMMERCE FUND TO SUPPORT HEALTHY FOOD ACCESS AND $250K TO THE BOSTON LOCAL INITIATIVES SUPPORT CORPORATION (LISC BOSTON) SMALL BUSINESS GROWTH FUND TO SUPPORT ECONOMIC EMPOWERMENT AND GROW BUSINESSES OWNED BY BLACK, LATINO, AND INDIGENOUS ENTREPRENEURS AND OTHER PEOPLE OF COLOR. THIS BUILDS ON DANA-FARBER'S PREVIOUS $1M INVESTMENT IN THE HEALTHY NEIGHBORHOOD EQUITY FUND II MADE IN FY21 TO ADDRESS HOUSING NEEDS IN GREATER BOSTON. DANA-FARBER PARTNERED WITH UNION CAPITAL BOSTON AND DF/HCC TO HOST FOUR CANCER AWARENESS RESOURCE NIGHTS FOCUSED ON BREAST CANCER SCREENING, TOBACCO CESSATION, HPV VACCINE, AND CANCER SURVIVORSHIP, ENGAGING OVER 500 RESIDENTS VIRTUALLY. THESE EVENTS FEATURED AN EDUCATION SESSION ON A CANCER-RELATED TOPIC, SURVIVOR TESTIMONY, AND QA SESSIONS WITH AUDIENCE MEMBERS. DANA-FARBER DEVELOPED A NEW CANCER-FOCUSED COMMUNITY HEALTH NEEDS ASSESSMENT AND IMPLEMENTATION PLAN FOR THE 2022-2025 TRIENNIAL CYCLE AND CONTINUED TO PLAY A LEADERSHIP ROLE IN THE BOSTON CHNA/CHIP COLLABORATIVE. |
| Form 990, Part VI, Line 2 Family/business relationships amongst interested persons | RICHARD LUBIN, CHRISTOPHER HADLEY, AND JANE BROCK-WILSON - Business relationship, JOSH BEKENSTEIN, ANDREW KAPLAN, AND NANCY LOTANE - Business relationship, PHILLIP GROSS AND DEMOND MARTIN - Business relationship, ANDREW JANOWER AND MICHAEL EISENSON - Business relationship, BRIAN KNEZ AND JESSICA KNEZ - Family relationship, JOHN O'CONNOR AND LAURA SEN - Family relationship |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | THE DANA-FARBER CANCER INSTITUTE TAX DEPARTMENT PROVIDES ALL FINANCIAL ANALYSIS AND OTHER INFORMATION TO BE INCLUDED ON THE TAX RETURN TO ITS EXTERNAL TAX PREPARER, ERNST YOUNG LLP, WHICH PREPARES THE DRAFT RETURN. THE DRAFT RETURN IS THEN REVIEWED BY THE DFCI TAX MANAGER, AS WELL AS THE DFCI OFFICE OF GENERAL COUNSEL AND SENIOR MANAGEMENT, BEFORE IT IS SUBMITTED FOR DFCI AUDIT COMMITTEE REVIEW. AFTER THE AUDIT COMMITTEE REVIEWS THE TAX RETURN, AN ELECTRONIC MESSAGE IS SENT TO ALL GOVERNING BOARD MEMBERS WITH A SECURE LINK TO THE TAX RETURN. THE BOARD HAS THE OPPORTUNITY TO REVIEW THE RETURN AND BRING ANY ISSUES TO THE ATTENTION OF THE APPROPRIATE EXECUTIVE MANAGEMENT INDIVIDUALS. A FINAL VERSION OF THE FORM IS APPROVED BY THE CFO AND FILED ELECTRONICALLY BY ERNST YOUNG LLP WITH THE IRS. |
| Form 990, Part VI, Line 12c Conflict of interest policy | DFCI MONITORS AND ENFORCES COMPLIANCE WITH THE DFCI CONFLICT-OF-INTEREST AND CONFIDENTIALITY POLICY FOR BOARD OFFICERS, TRUSTEES, AND KEY EMPLOYEES ("COVERED PERSONS"). THE OFFICE OF THE GENERAL COUNSEL ANNUALLY DISTRIBUTES A CONFLICT OF INTEREST QUESTIONNAIRE AND CONFIDENTIALITY STATEMENT ("STATEMENT") REQUIRING ALL COVERED PERSONS TO DISCLOSE INTERESTS, ROLES, AND ACTIVITIES THAT COULD GIVE RISE TO A POTENTIAL OR ACTUAL CONFLICT WITH THE INTERESTS OF DFCI. IF A TRUSTEE FAILS TO COMPLETE THE ANNUAL STATEMENT. THE CHAIR OF THE GOVERNANCE COMMITTEE MAY TAKE ACTIONS TO SUSPEND THE TRUSTEE. DFCI REQUIRES COVERED PERSONS TO COMPLETE THE STATEMENT UPON INITIAL APPOINTMENT TO A COVERED OFFICE AND TO UPDATE THEIR DISCLOSURES ON A CONTINUING BASIS WHENEVER A COVERED PERSON BECOMES AWARE OF A NEW OR PREVIOUSLY UNDISCLOSED INTEREST. THE OFFICE OF GENERAL COUNSEL COMPARES THE DISCLOSURES TO INSTITUTIONAL INFORMATION IN ORDER TO IDENTIFY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. THE DFCI GENERAL COUNSEL REPORTS ON ALL DISCLOSURES TO THE DFCI PRESIDENT, CHAIR OF THE DFCI BOARD AND CHAIR OF THE DFCI BOARD GOVERNANCE COMMITTEE. THE BOARD IS RESPONSIBLE UNDER THE COI POLICY FOR ADDRESSING ISSUES RELATED TO CONFLICTS OF COVERED PERSONS. A PROPOSED ARRANGEMENT CREATING A CONFLICT OF INTEREST MAY BE APPROVED IF APPROPRIATE STEPS ARE TAKEN TO ENSURE THAT DFCI MAKES A DECISION IN AN OBJECTIVE AND FAIR MANNER CONSISTENT WITH THE HIGHEST ETHICAL AND LEGAL STANDARDS. SUCH STEPS INCLUDE RECUSAL OF THE COVERED PERSON WITH A CONFLICT OF INTEREST FROM NEGOTIATIONS OR DISCUSSIONS ON BEHALF OF DFCI OR THE ENTITY WITH WHICH DFCI IS DOING BUSINESS AND FROM BOARD OR DFCI MANAGEMENT DISCUSSIONS OF SUCH ARRANGEMENT. |
| Form 990, Part VI, Line 15a Process to establish compensation of top management official | PER DFCI'S EXECUTIVE COMPENSATION PHILOSOPHY, ANNUALLY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES REVIEWS THE PRESIDENT'S (DFCI'S CHIEF EXECUTIVE OFFICER) PERFORMANCE AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE ACTS ON THE RECOMMENDATION. TO ENSURE COMPLIANCE WITH THE PHILOSOPHY, THE COMPENSATION COMMITTEE BI-ANNUALLY COMMISSIONS AN INDEPENDENT REVIEW BY A THIRD-PARTY EXECUTIVE COMPENSATION CONSULTANT TO COMPARE SUCH COMPENSATION WITH THAT OF OTHER SIMILARLY SITUATED INDIVIDUALS IN THE HEALTHCARE FIELD IN AND OUTSIDE OF THE REGION. THE DECISION OF THE EXECUTIVE COMMITTEE IS REPORTED TO THE FULL BOARD. THE BOARD COMPLETED THIS PROCESS AS OF JUNE 2022. |
| Form 990, Part VI, Line 15b Process to establish compensation of other employees | PROCESS FOR DETERMINING COMPENSATION OF OFFICERS AND KEY EMPLOYEES PER DFCI'S EXECUTIVE COMPENSATION PHILOSOPHY, ANNUALLY THE DFCI PRESIDENT REVIEWS THE PERFORMANCE OF OFFICERS AND KEY EMPLOYEES. THE PRESIDENT MAKES A RECOMMENDATION AS TO THE COMPENSATION OF THOSE INDIVIDUALS WHO ARE DISQUALIFIED PERSONS OF DFCI TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES. THE COMPENSATION COMMITTEE APPROVES COMPENSATION FOR THOSE INDIVIDUALS BASED ON THAT RECOMMENDATION. FOR KEY EMPLOYEES WHO ARE NOT DISQUALIFIED PERSONS, THE PRESIDENT REPORTS TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES ON HER DETERMINATION OF COMPENSATION FOR THOSE INDIVIDUALS. TO ENSURE COMPLIANCE WITH THE PHILOSOPHY, THE PRESIDENT AND COMPENSATION COMMITTEE BIANNUALLY RECEIVE A REPORT BY A THIRD-PARTY EXECUTIVE COMPENSATION CONSULTANT. THE REPORT ANALYZES THE COMPETITIVENESS OF THE TOTAL COMPENSATION PROGRAM FOR DISQUALIFIED PERSONS AGAINST MARKET DATA REPRESENTING DFCI'S LOCAL AND NATIONAL PEER ORGANIZATIONS. THE PRESIDENT MAKES RECOMMENDATIONS FOR MARKET ADJUSTMENTS AS NEEDED FOR THOSE INDIVIDUALS WHO ARE DISQUALIFIED PERSONS OF DFCI TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES. THE COMPENSATION COMMITTEE APPROVES MARKET ADJUSTMENTS FOR THOSE INDIVIDUALS BASED ON THE PRESIDENT'S RECOMMENDATION. THE BOARD COMPLETED THIS PROCESS AS OF JUNE 2022. FOR KEY EMPLOYEES WHO ARE NOT DISQUALIFIED PERSONS, THE PRESIDENT REPORTS TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES ON HER DETERMINATION OF MARKET ADJUSTMENTS AS NEEDED FOR THOSE INDIVIDUALS. |
| Form 990, Part VI, Line 19 Required documents available to the public | GOVERNING DOCUMENTS THE GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST. THE GOVERNING DOCUMENTS ARE ALSO AVAILABLE TO THE PUBLIC ON THE SECRETARY OF THE COMMONWEALTH'S WEBSITE. CONFLICT OF INTEREST POLICY DANA-FARBER CANCER INSTITUTE'S BOARD OF TRUSTEES CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS THE ORGANIZATION USES THE SERVICES OF DIGITAL ASSURANCE CERTIFICATION LLC (DAC) TO REPORT ANNUAL AUDITED FINANCIAL STATEMENTS AND OTHER RELEVANT ORGANIZATIONAL INFORMATION AS REQUIRED BY CERTAIN REGULATORY AND TAX LAWS. DAC IS A WEBSITE (WWW.DACBOND.COM) FREE TO THE PUBLIC THAT PUBLISHES TAX-EXEMPT BOND ISSUERS' FINANCIAL AND LEGAL DOCUMENTS SUCH AS THE AUDITED FINANCIAL STATEMENTS. FISCAL YEAR 2016 THROUGH THE LATEST ISSUE DATE OF THE AUDITED FINANCIAL STATEMENTS FOR DANA-FARBER CANCER INSTITUTE, INC. CAN BE FOUND ON THE DAC WEBSITE. ANNUAL AUDITED FINANCIAL STATEMENTS FROM FISCAL YEAR 1998 THROUGH FISCAL YEAR 2015 ARE AVAILABLE UPON REQUEST. |
| Form 990, Part VII, Section B, Line 1 | THE AMOUNT PAID TO WALSH BROTHERS, INC. INCLUDED COSTS FOR BUILDING SERVICES AND MATERIALS. HOWEVER, THE ORGANIZATION WAS UNABLE TO OBTAIN INFORMATION TO BREAKOUT THE EXACT AMOUNT FOR MATERIAL COSTS. |
| Form 990, Part VIII, Line 11d Other Miscellaneous Revenue | ALL OTHER - Total Revenue: 2815275, Related or Exempt Function Revenue: , Unrelated Business Revenue: 65661, Revenue Excluded from Tax Under Sections 512, 513, or 514: 2749614; |
| Form 990, Part XI, Line 9 Other changes in net assets or fund balances | CHANGE IN INTEREST IN ASSETS HELD BY AFFILIATES - -XXX-XX-XXXX; CHANGE IN VALUE OF SWAP AGREEMENT - 38290151; PENSION ADJUSTMENT - 4980580; |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Total IncomeTotalIncomeAmt | End Of Year AssetsEndOfYearAssetsAmt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|---|
| DANA-FARBER GLOBAL ONCOLOGY LLC | ||||||||||
| 450 BROOKLINE AVENUE | BP418 | BOSTON | MA | 02215 | 851914853 | INT. ONCOLOGY | MA | $3,830,903 | $7,589,191 | DFCI |
| BINNEY STREET CAPITAL FUND LLC | ||||||||||
| 450 BROOKLINE AVE | BP418 | BOSTON | MA | 02215 | INVESTMENTS | DE | -$1,234,555 | $3,490,766 | DFI | |
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (7 entries)
| Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DANA-FARBER INC | |||||||||||
| 450 BROOKLINE AVENUE | BP418 | BOSTON | MA | 02215 | 043102433 | INVESTMENT MANAGEMENT | MA | 501(c)(3) | Type I | DFCI | Yes (true) |
| DANA-FARBER TRUST INC | |||||||||||
| 450 BROOKLINE AVENUE | BP418 | BOSTON | MA | 02215 | 300195757 | RECEIVE REAL ESTATE GIFTS FOR DFCI | MA | 501(c)(3) | Type I | DFCI | Yes (true) |
| DANA-FARBERMASS GEN BRIGHAM CANCER CARE | |||||||||||
| 450 BROOKLINE AVENUE | BP418 | BOSTON | MA | 02215 | 043320640 | ONCOLOGY RESEARCH | MA | 501(c)(3) | Type I | NA | false |
| RMSA TRUST | |||||||||||
| 450 BROOKLINE AVENUE | BP418 | BOSTON | MA | 02215 | 562656539 | VEBA TRUST | MA | 501(c)(9) | DFCI | Yes (true) | |
| FRIENDS OF DANA-FARBER CANCER INSTITUTE | |||||||||||
| 450 BROOKLINE AVENUE | BP418 | BOSTON | MA | 02215 | 371613621 | FUNDRAISING | MA | 501(c)(3) | Type I | DFCI | Yes (true) |
| DANA-FARBERCHILDREN'S HOSP CANCER CARE | |||||||||||
| 450 BROOKLINE AVENUE | BP418 | BOSTON | MA | 02215 | 043554536 | PEDIATRIC ONCOLOGY | MA | 501(c)(3) | Type I | NA | false |
| DANA-FARBER CANCER CARE NETWORK INC | |||||||||||
| 450 BROOKLINE AVENUE | BP418 | BOSTON | MA | 02215 | 465138314 | ONCOLOGY CARE | MA | 501(c)(3) | 10 | DFCI | Yes (true) |
Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MGB DF INTL LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 399 REVOLUTION DR | AddressLine1Txt |
| Address Line2 | STE 645 | AddressLine2Txt |
| City | SOMERVILLE | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02145 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 871595882 | EIN |
| Primary Activities | INTERNATIONAL CONSULTING | PrimaryActivitiesTxt |
| Legal Domicile State | DE | LegalDomicileStateCd |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | NA | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Predominant Income Type | N/A | PredominantIncomeTypeTxt |
| Share Of Total Income | -$5,267 | ShareOfTotalIncomeAmt |
| Share Of EOY Assets | -$5,267 | ShareOfEOYAssetsAmt |
| Disproportionate Allocations | false | DisproportionateAllocationsInd |
| General Or Managing Partner | false | GeneralOrManagingPartnerInd |
| Ownership | 0.5 | OwnershipPct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (true) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | Yes (true) | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (6 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| Dana-Farber Inc | ||
| S | $332,040,564 | Cash |
| Dana-Farber Inc | ||
| R | $156,581,944 | Cash |
| Friends of Dana-Farber Cancer Institute Inc | ||
| C | $637,712 | cash |
| Friends of Dana-Farber Cancer Institute Inc | ||
| O | $286,629 | actual exp |
| RMSA Trust | ||
| R | $249,066 | Cash |
| Dana-Farber Cancer Care Network Inc | ||
| P | $201,449 | Cost |